<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83578</article-id><article-id pub-id-type="doi">10.7554/eLife.83578</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-123658"><name><surname>Verstegen</surname><given-names>Niels JM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5732-4979</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-293427"><name><surname>Pollastro</surname><given-names>Sabrina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0950-7583</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293428"><name><surname>Unger</surname><given-names>Peter-Paul A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277482"><name><surname>Marsman</surname><given-names>Casper</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-230337"><name><surname>Elias</surname><given-names>George</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8419-9544</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293429"><name><surname>Jorritsma</surname><given-names>Tineke</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293430"><name><surname>Streutker</surname><given-names>Marij</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293431"><name><surname>Bassler</surname><given-names>Kevin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4780-372X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293432"><name><surname>Haendler</surname><given-names>Kristian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271349"><name><surname>Rispens</surname><given-names>Theo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293433"><name><surname>Schultze</surname><given-names>Joachim L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286316"><name><surname>ten Brinke</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293434"><name><surname>Beyer</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-286315"><name><surname>van Ham</surname><given-names>S Marieke</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1999-9494</contrib-id><email>m.vanham@sanquin.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dkp9463</institution-id><institution>Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dkp9463</institution-id><institution>Synthetic Systems Biology and Nuclear Organization, Swammerdam Institute for Life Sciences, University of Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Genomics and Immunoregulation, University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE), University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043j0f473</institution-id><institution>Immunogenomics &amp; Neurodegeneration, German Center for Neurodegenerative Diseases</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dkp9463</institution-id><institution>Swammerdam Institute for Life Sciences, University of Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Choi</surname><given-names>Murim</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Choi</surname><given-names>Murim</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>02</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e83578</elocation-id><history><date date-type="received" iso-8601-date="2022-09-20"><day>20</day><month>09</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-02-24"><day>24</day><month>02</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-10-05"><day>05</day><month>10</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.03.510595"/></event></pub-history><permissions><copyright-statement>© 2023, Verstegen, Pollastro et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Verstegen, Pollastro et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83578-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-83578-figures-v2.pdf"/><abstract><p>Differentiation of B cells into antibody-secreting cells (ASCs) is a key process to generate protective humoral immunity. A detailed understanding of the cues controlling ASC differentiation is important to devise strategies to modulate antibody formation. Here, we dissected differentiation trajectories of human naive B cells into ASCs using single-cell RNA sequencing. By comparing transcriptomes of B cells at different stages of differentiation from an in vitro model with ex vivo B cells and ASCs, we uncovered a novel pre-ASC population present ex vivo in lymphoid tissues. For the first time, a germinal-center-like population is identified in vitro from human naive B cells and possibly progresses into a memory B cell population through an alternative route of differentiation, thus recapitulating in vivo human GC reactions. Our work allows further detailed characterization of human B cell differentiation into ASCs or memory B cells in both healthy and diseased conditions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>B cell</kwd><kwd>antibody-secreting cell</kwd><kwd>single-cell RNA sequencing</kwd><kwd>differentiation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009425</institution-id><institution>Landsteiner Foundation for Blood Transfusion Research</institution></institution-wrap></funding-source><award-id>LSBR 1609</award-id><principal-award-recipient><name><surname>van Ham</surname><given-names>S Marieke</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012023</institution-id><institution>Sanquin Blood Supply Foundation</institution></institution-wrap></funding-source><award-id>PPOC17-34/ L2263</award-id><principal-award-recipient><name><surname>van Ham</surname><given-names>S Marieke</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>272482170</award-id><principal-award-recipient><name><surname>Beyer</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB1454-432325352</award-id><principal-award-recipient><name><surname>Beyer</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Single-cell RNA sequencing provides a detailed understanding of the cues controlling in vitro differentiation of human B cells into antibody-secreting cells (ASCs), uncovering a novel pre-ASC population present ex vivo in lymphoid tissues that progress through a germinal center-like state.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Protection from invading pathogens is, in part, provided by antibody-secreting cells (ASCs) that secrete high-affinity class-switched antibodies. Antibody formation, however, can also be highly undesired. This is the case for detrimental autoantibodies in autoimmune disorders, for alloantibodies that react with donor blood cells after a blood transfusion, or for antibodies that are formed against therapeutic biologics and that interfere with their therapeutic efficacy. Plasma cells secreting high-affinity antibodies are generated from naive B cells that, upon foreign antigen recognition by the antigen-specific B cell receptor (BCR), get activated and after CD4 T cell help can start a germinal center (GC) reaction. Here, B cells differentiate into GC B cells and begin to cycle between the GC dark zone (DZ) and the GC light zone (LZ). In the former, GC B cells undergo several rounds of cell cycle and receptor editing processes, such as somatic hypermutation and class-switching. In the latter, B cells need to reacquire antigen and present antigenic peptides to cognate antigen-specific CD4 T follicular helper (Tfh) cells to receive the required co-stimulatory, survival, and differentiation signals (<xref ref-type="bibr" rid="bib13">Bryant et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">King and Mohrs, 2009</xref>; <xref ref-type="bibr" rid="bib32">King et al., 2008</xref>; <xref ref-type="bibr" rid="bib49">Reinhardt et al., 2009</xref>; <xref ref-type="bibr" rid="bib73">Yusuf et al., 2010</xref>; <xref ref-type="bibr" rid="bib25">Glatman Zaretsky et al., 2009</xref>). After several rounds of DZ to LZ cycling, this process results in the selection of high-affinity, class-switched B cells (reviewed in <xref ref-type="bibr" rid="bib68">Victora and Nussenzweig, 2022</xref>). While early memory B cell and early plasmablast formation occur before GC establishment (<xref ref-type="bibr" rid="bib24">Glaros et al., 2021</xref>), the GC reactions give rise to a later stage, higher affinity memory B cell formation followed by the eventual formation of high-affinity, ASCs (plasmablasts and plasma cells) (<xref ref-type="bibr" rid="bib71">Weisel et al., 2016</xref>). Migration of plasma cells to the bone marrow and incorporation into bone marrow survival niches establishes long-lived plasma cells that may secrete antibodies for decades (<xref ref-type="bibr" rid="bib8">Belnoue et al., 2008</xref>; <xref ref-type="bibr" rid="bib17">Cassese et al., 2003</xref>; <xref ref-type="bibr" rid="bib48">Radbruch et al., 2006</xref>).</p><p>The transition of B cell into ASC is tightly regulated on the molecular level by a complex network of transcription factors that control the switch from the B cell stage to the ASC stage (reviewed in <xref ref-type="bibr" rid="bib66">Verstegen et al., 2021</xref>). The ASC-specific transcription factors IRF4, XBP1, and BLIMP1 are upregulated only once the B cell-specific transcription factors PAX5, IRF8, and BACH2 are downregulated. These transcriptional changes are then followed by surface expression of stage-specific cellular markers, such as CD27, CD38, and CD138 on ASCs, with simultaneous downregulation of the B cell markers CD19 and CD20 (<xref ref-type="bibr" rid="bib39">Loken et al., 1987</xref>; <xref ref-type="bibr" rid="bib54">Sanderson et al., 1989</xref>; <xref ref-type="bibr" rid="bib60">Tangye et al., 1998</xref>; <xref ref-type="bibr" rid="bib62">Terstappen et al., 1990</xref>; <xref ref-type="bibr" rid="bib67">Victora et al., 2012</xref>).</p><p>Although these transcription factors associated with plasma cell differentiation and plasma cell markers have been well-studied, the differentiation trajectories of naive B cells into short-lived and long-lived ASCs and the regulators that control transition at the different stages of human B cell differentiation remain largely unknown. Bulk RNA sequencing on sorted B cells ex vivo has identified differences between naive B cells, GC B cells, memory B cells, plasmablasts, and plasma cells (<xref ref-type="bibr" rid="bib28">Halliley et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Minnich et al., 2016</xref>; <xref ref-type="bibr" rid="bib61">Tarte et al., 2003</xref>), but does not allow delineation of the actual differentiation process and the various stages through which B cells transition to becoming ASCs. The development of single-cell sequencing techniques circumvents this problem and allows for the discovery of new cellular subsets and cells that are transitioning from one cellular differentiation state to another. To date, single-cell sequencing has been used, among others, to identify B cell subsets in the immune landscape of tumor-infiltrating lymphocytes (<xref ref-type="bibr" rid="bib18">Chung et al., 2017</xref>), delineate malignant B cells in follicular lymphomas (<xref ref-type="bibr" rid="bib3">Andor et al., 2019</xref>), and identify transiting bone marrow progenitor cell populations that commit to the B cell lineage (<xref ref-type="bibr" rid="bib2">Alberti-Servera et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Miyai et al., 2018</xref>). In addition, software to reconstruct B cell receptor sequences from single-cell RNA sequencing data has been developed in recent years (<xref ref-type="bibr" rid="bib16">Canzar et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Lindeman et al., 2018</xref>; <xref ref-type="bibr" rid="bib50">Rizzetto et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Upadhyay et al., 2018</xref>). In-depth characterization of the differentiation process of mature naive B cells into ASCs has been investigated by focusing on parts of this differentiation process, for example, GC LZ to DZ migration (<xref ref-type="bibr" rid="bib20">Dominguez-Sola et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Milpied et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Sander et al., 2015</xref>). Although this contributed to new insights into GC reactions, it remains unclear how differentiation into plasma cells occurs and is regulated. More insight into this differentiation process might uncover targets to regulate B cell differentiation into ASC at an early stage and to intervene in the generation of undesired antibodies in disease.</p><p>We previously established a minimalistic in vitro culture system that uniquely supports efficient in vitro differentiation of human naive B cells into CD27<sup>++</sup>CD38<sup>++</sup> ASCs while also maintaining high cell numbers along the differentiation stages (<xref ref-type="bibr" rid="bib63">Unger et al., 2021</xref>). Here, we applied in-depth single-cell transcriptomics, B cell receptor reconstruction and trajectory inference on the in vitro-generated ASCs and combined analyses with data from publicly available single-cell datasets of ex vivo obtained B cells and ASCs from different human tissues. Our data demonstrate that in vitro-generated ASCs are highly comparable to their ex vivo counterparts. The differentiation trajectories uncover a hitherto unknown pre-ASC cellular stage that is detected also ex vivo in lymphoid tissue with active ASC differentiation processes. For the first time, GC-like B cells are identified in vitro from human naive B cells and possibly progress through an alternative route of differentiation into memory B cells. In addition to known regulatory transcription factors and cell surface markers, potential novel transcriptional regulators and plasma membrane markers are identified that may control or, respectively, mark the process of human plasma cell differentiation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell transcriptomic analysis of in vitro differentiated antibody-secreting cells</title><p>We previously described a minimalistic in vitro system that effectively differentiates human naive B cells into ASCs while also maintaining high cell numbers at the various stages of B cell differentiation (<xref ref-type="bibr" rid="bib63">Unger et al., 2021</xref>). Briefly, human naive B cells (CD19<sup>+</sup>CD27<sup>-</sup>IgG<sup>-</sup>IgD<sup>+</sup>) are sorted from healthy donor peripheral blood mononucleated cells (PBMCs) and cultured on a feeder layer of human CD40L-expressing mouse fibroblasts and restimulated after 6 days. Cytokines typically expressed by follicular T cells (Tfh) (IL-21, IL-4) are added to mimic Tfh help for B cell differentiation. Restimulation with CD40 costimulation and Tfh cytokines in vitro was demonstrated to be needed to drive efficient ASC differentiation, in line with in vivo GC reactions (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Triggering of the IgM BCR with soluble anti-IgM antibodies or IgM-coated beads did not contribute to enhanced ASC differentiation in the minimalistic cultures (<xref ref-type="bibr" rid="bib63">Unger et al., 2021</xref>). To assess the transition of naive B cells (CD27<sup>-</sup>CD38<sup>-</sup>) into ASCs (CD27<sup>++</sup>CD38<sup>++</sup>), cells from the four CD27/CD38 quadrants were sorted on day 11 and the expression of master regulators of B cells to ASC differentiation was analyzed (<xref ref-type="fig" rid="fig1">Figure 1b</xref>; <xref ref-type="bibr" rid="bib66">Verstegen et al., 2021</xref>). CD27<sup>-</sup>CD38<sup>-</sup> cells gradually lose expression of B cell signature genes <italic>PAX5</italic> and <italic>BACH2</italic> upon acquisition of CD27 and/or CD38 expression with CD27<sup>++</sup>CD38<sup>++</sup> cells showing the most downregulated expression of <italic>PAX5</italic> and <italic>BACH2</italic> and upregulation of ASC signature genes <italic>IRF4</italic>, <italic>XBP1</italic>, and <italic>PRDM1</italic> (<xref ref-type="fig" rid="fig1">Figure 1c–g</xref>). In line with this, CRISPR-Cas9-mediated knockout of <italic>PRDM1</italic> on day 3 strongly suppressed the formation of CD27<sup>+</sup>CD38<sup>+</sup> cells on day 11 compared to control and <italic>CD19</italic> knockout (<xref ref-type="fig" rid="fig1">Figure 1h</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Unbiased analysis of in vitro-induced human naive B cell differentiation by scRNA-seq reveals five transcriptionally distinct B cell clusters.</title><p>(<bold>a</bold>) Overview of the scRNA-seq experiment in short human naive B cells was isolated and cultured with a human CD40L-expressing mouse fibroblast (3T3) cell line and recombinant IL-4. Secondary cultures were initiated on day 6 using 9:1 wild type (WT) 3T3 to CD40L-expressing 3T3 cells and IL-4/IL-21 as this was necessary to induce substantial differentiation into the CD27<sup>++</sup>CD38<sup>++</sup> ASC subset. On day 11, 384 cells were single-cell sorted based on the expression of CD27 and CD38 and sequenced using the Smart-seq2 method. (<bold>b</bold>) Overview of the cellular stages and important transcription factors involved in B cells differentiation from naive to antibody-secreting cell (GC, germinal center; ASC, antibody-secreting cell). (<bold>c–g</bold>) Expression of <italic>PAX5</italic> (<bold>c</bold>), <italic>BACH2</italic> (<bold>d</bold>), <italic>IRF4</italic> (<bold>e</bold>), <italic>XBP1</italic> (<bold>f</bold>), and <italic>PRMD1</italic> (<bold>g</bold>) mRNA in sorted populations was analyzed by qPCR and related to levels present in CD27<sup>-</sup>CD38<sup>-</sup> cells. Each data point represents the mean of an individual experiment (n = 3) with triplicate measurements. Mean values are represented as bars. (<bold>h</bold>) FACS analysis of surface CD19 levels (top left) and ASC differentiation (top right) in cultured primary human B cells expressing the indicated control or CD19-targeting RNP. FACS analysis of ASC differentiation (bottom left) and quantification (bottom right) in cultured primary human B cells expressing the indicated control or three different <italic>PRDM1</italic>-targeting RNPs. Representative of three independent experiments with triplicate measurements. (<bold>i</bold>) Uniform Manifold Approximation and Projection (UMAP) projection of single-cell transcriptomes of in vitro differentiated human naive B cells (276 high-quality cells). Each point represents one cell, and colors indicate graph-based cluster assignments. (<bold>j–o</bold>) UMAP projection as in (<bold>i</bold>) colored by the transcriptional regulators <italic>IRF4</italic> (<bold>j</bold>), <italic>XBP1</italic> (<bold>k</bold>) and <italic>PRMD1</italic> (<bold>l</bold>), <italic>PAX5</italic> (<bold>m</bold>), <italic>BACH2</italic> (<bold>n</bold>), <italic>SPIB</italic> (<bold>o</bold>), which are important in B cell differentiation (left graph of each panel), along with corresponding distribution of average expression levels (ln(TPM+1)) across the B cell clusters (1, 2, and 3) and the ASC clusters (4 and 5) (right graph of each panel).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>scRNA-seq analysis of differentiating human B cells.</title><p>(<bold>a</bold>) Schematic overview of the analysis pipeline. (<bold>b</bold>) Violin plot depicting the number of genes in each of the four sorted populations based on CD27 and CD38 expression. (<bold>c</bold>) Scatter plot showing the percentage alignment and the proportion of mitochondrial genes per single cell. (<bold>d</bold>) Stacked bars denote the frequency of the four sorted populations based on CD27 and CD38 expression before and after quality control. (<bold>e</bold>) The number of principal components (PC; x-axis) with the variance in gene expression explained by each component. The top 10 PCs were selected for further analysis. (<bold>f</bold>) Distribution of the different cell-cycle phases (Gap 1(G1), Gap 2/mitosis (G2/M), and synthesis (<bold>S</bold>)) among the 276 high-quality single cells. (<bold>g–h</bold>) Uniform Manifold Approximation and Projection (UMAP) projection of single-cell transcriptomes of in vitro differentiated human naive B cells without (<bold>g</bold>) and with (<bold>h</bold>) cell-cycle regression. Each point represents one cell, and colors indicate the cell-cycle phase. (<bold>i</bold>) Mean cell-cycle phase frequencies within each of the B cell subsets that were identified after cell-cycle regression. (<bold>j</bold>) UMAP projection of single-cell transcriptomes of in vitro differentiated human naive B cells without cell-cycle regression. Each point represents one cell, and colors indicate graph-based cluster assignments identified with cell-cycle regression.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Subset distribution of differentiating primary human B cells.</title><p>(<bold>a</bold>) Uniform Manifold Approximation and Projection (UMAP) projection (left) as in <xref ref-type="fig" rid="fig1">Figure 1i</xref> colored by the four sorted populations based on CD27 and CD38 expression. Barplot show the relative abundance of CD27<sup>-</sup>CD38<sup>-</sup> CD27<sup>+</sup>CD38<sup>-/+</sup>, CD27<sup>++</sup>CD38<sup>++</sup>, CD27<sup>-</sup>CD38<sup>+</sup> cells among the five transcriptionally distinct clusters (right). (<bold>b</bold>) Dot plot showing combined CD27 and CD38 protein expression values of cells from each cluster (left). Barplot show the relative abundance of the five transcriptionally distinct clusters within the CD27<sup>-</sup>CD38<sup>-</sup> CD27<sup>+</sup>CD38<sup>-/+</sup>, CD27<sup>++</sup>CD38<sup>++</sup>, and CD27<sup>-</sup>CD38<sup>+</sup> populations (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig1-figsupp2-v2.tif"/></fig></fig-group><p>Since the minimalistic in vitro system efficiently drives differentiation of primary human naive B cells into ASCs and follows the in vivo observed transitions of the master regulators of transcription, the dynamics of human naive B cell differentiation were investigated in detail by single-cell RNA sequencing. Cultured cells were single-cell sorted on day 11 based on the expression of CD27 and CD38 to obtain a faithful representation of cells at varying stages of B cell to ASC differentiation. Next, cells were processed for single-cell RNA sequencing using the SMARTseq2 method. After raw data processing and quality control, a total of 275 (out of 382 sorted cells) high-quality cells that together express 17,716 genes were included in the final dataset (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a–e</xref>). Cells were assigned to one of three phases of the cell cycle (G1, G2/M, S) as determined by scores calculated based on the expression of G2/M and S phase genes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1f</xref>). As the cell cycle is an essential component of GC reactions, data were analyzed with and without regressing cell-cycle heterogeneity. When the cell cycle was not regressed out, cells were clustered based on cell-cycle scores, and most differentially expressed genes were related to the cell cycle (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1g</xref>). Cell-cycle heterogeneity was regressed out in the final dataset to primarily focus our analysis on factors influencing B cells differentiation apart from the cell cycle (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1h and i</xref>).</p><p>Unsupervised hierarchical clustering and visualization with Uniform Manifold Approximation and Projection (UMAP) identified five clusters of differentiating cells (<xref ref-type="fig" rid="fig1">Figure 1i</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1j</xref>). Clusters 4 and 5 showed a clear ASC gene signature with a prominent expression of known ASC-specific genes <italic>IRF4</italic>, <italic>XBP1,</italic> and <italic>PRDM1</italic> (<xref ref-type="fig" rid="fig1">Figure 1j–l</xref>). Of note, 99% of CD27<sup>+</sup>CD38<sup>+</sup> double-positive sorted cells were represented in clusters 4 and 5 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a and b</xref>). The other three clusters (clusters 1–3) still showed a pronounced B cell signature with higher expression of genes known to repress the ASCs state such as <italic>PAX5</italic>, <italic>BACH2,</italic> and <italic>SPIB</italic> (<xref ref-type="fig" rid="fig1">Figure 1m–o</xref>). Thus, upon 11 days of culture with CD40 costimulation and IL-21/IL-4, human naive B cells differentiate into distinct B cells and ASC clusters based on overall gene signatures.</p></sec><sec id="s2-2"><title>In vitro-generated ASCs are highly comparable with ex vivo obtained ASCs from different human tissues</title><p>To further characterize in vitro-generated ASCs, transcribed immunoglobulin genes were reconstructed from the single-cell transcriptomic data using <italic>BraCeR,</italic> and transcription levels and properties of immunoglobulins genes were compared between B cell and ASC clusters. A functional B cell receptor heavy chain rearrangement was successfully reconstructed for 255 out of 276 cells analyzed. Expression of the reconstructed B cell receptor (BCR) genes in clusters 4 and 5 was up to 10 times higher compared to clusters 1–3, demonstrating a very high transcriptional activity of immunoglobulin genes in the ASC clusters (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). Isotype analysis of the reconstructed BCR heavy chains revealed a homogeneous distribution of isotypes in the different clusters (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a and b</xref>). When combining data for B cell and ASC clusters, the percentage of cells expressing immunoglobulin of the IgM isotype was lower in clusters 4 and 5 compared to clusters 1–3 (clusters 4 and 5: 36.6% vs. clusters 1–3: 50.3%; p-value&lt;0.01), while the opposite was true for expression of immunoglobulins of the IgG1 isotype (cluster 4 and 5: 43.7% vs. cluster 1–3: 24.6%; p-value &lt;0.001). In addition, 87% (226/255) of all the reconstructed BCR heavy genes were identical to the germline sequence, that is, not somatically hypermutated, independently of their cluster origin (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). Thus, in vitro-generated ASCs express a high load of, mostly, IgG1 class-switched but no significant mutated immunoglobulin genes.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification of antibody-secreting cells with substantial gene expression overlap as compared to ex vivo-derived plasmablast/plasma cells among the in vitro-differentiated human naive B cells.</title><p>(<bold>a</bold>) Violin plot of the reconstructed B cell receptor immunoglobulins gene expression as determined by BraCeR within each B cell cluster. (<bold>b</bold>) Stacked bars denotes the frequency of isotype analysis of the reconstructed immunoglobulin heavy chain within each cluster. (<bold>c</bold>) Stacked bars showing the percentage of cells with a given B cell receptor mutation count within each B cell cluster. (<bold>d–g</bold>) Volcano plot depicting significantly (adjusted p-value &lt;0.05) down- and upregulated genes. (<bold>d</bold>) In vitro-generated antibody-secreting cells (clusters 4 and 5), ex vivo bone marrow-derived plasma cells (<bold>e</bold>), ex vivo peripheral blood-derived plasmablast (<bold>f</bold>), and ex vivo tonsil-derived plasmablast/plasma cells (<bold>g</bold>) were compared to each specific B cell counterparts. (<bold>h, i</bold>) UpSetR plot (<bold>h</bold>) and Venn diagram (<bold>i</bold>) depict the intersection among all upregulated genes identified in in vitro and ex vivo antibody-secreting cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The distribution of heavy immunoglobulin gene in differentiating primary human B cells.</title><p>(<bold>a</bold>) Mean antibody subclass frequencies within each B cell subset. (<bold>b</bold>) Uniform Manifold Approximation and Projection (UMAP) projection as in <xref ref-type="fig" rid="fig1">Figure 1i</xref> colored by the reconstructed immunoglobulin heavy chain isotype.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Selection of bone marrow-derived mature B cells and antibody-secreting cells.</title><p>(<bold>a</bold>) Schematics of scRNA-seq on bone marrow-derived immunocytes derived from eight human donors. (<bold>b</bold>) Uniform Manifold Approximation and Projection (UMAP) plot of single-cell transcriptomes of bone marrow-derived B cells and antibody-secreting plasma cells. Each point is one cell, and colors indicate graph-based cluster assignments. (<bold>c, d</bold>) UMAP plot of single-cell transcriptomes of bone marrow-derived B cells and antibody-secreting plasma cells, colored by expression of indicated B cell (<bold>c</bold>) and plasma cell (<bold>d</bold>) marker genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Gene expression characteristics of peripheral blood naive B cells, memory B cells, and plasmablast.</title><p>(<bold>a</bold>) Schematics of scRNA-seq on sort purified naive B cells, memory b cells, and plasmablast derived from healthy human peripheral blood. (<bold>b</bold>) Uniform Manifold Approximation and Projection (UMAP) plot of single-cell transcriptomes of peripheral human naive B cells and plasmablast. Each point is one cell, and colors indicate graph-based cluster assignments. (<bold>c</bold>) Heatmap of the 15 most differentially expressed genes significantly enriched in each cell cluster. (<bold>d-f</bold>) Violin plots of previously characterized naive B cell (d), memory b cell (e), and plasmablast (f) specific marker genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Gene expression characteristics of tonsillar memory B cells, germinal center (GC) B cells, and plasmablast/plasma cells.</title><p>(<bold>a</bold>) Schematics of scRNA-seq on sort purified memory b cells, GC B cells, and plasmablast/plasma cells derived from human tonsils. (<bold>b</bold>) Uniform Manifold Approximation and Projection (UMAP) plot of single-cell transcriptomes of tonsillar memory b cells, GC B cells, and plasmablast/plasma cells. Each point is one cell, and colors indicate graph-based cluster assignments. (<bold>c</bold>) UMAP plot as in <bold>b</bold> annotated by the cell-cycle phase. (<bold>d</bold>) Heatmap of the 20 most differentially expressed genes significantly enriched in each cell cluster. (<bold>e–g</bold>) Violin plots of previously characterized memory B cell (<bold>e</bold>), GC b cell (<bold>f</bold>), and plasmablast/plasma cell (<bold>g</bold>) specific marker genes. UMAP projection (left), along with corresponding distribution of average expression levels (ln(TP10k+1)), across the different B cell subsets (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig2-figsupp4-v2.tif"/></fig></fig-group><p>To assess how the transcriptional profile of the in vitro-generated ASCs was representative of the in vivo situation, the specific gene signature of the in vitro-generated ASCs was first identified by performing differential expression analysis in the ASC clusters 4 and 5 compared to the B cell clusters 1–3 (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). A total of 3858 genes were differentially expressed in the ASC clusters, with 1406 overexpressed among which <italic>PRDM1</italic> and <italic>XBP1</italic> were top hits. Next, publicly available scRNA-seq datasets from bone marrow from the Human Cell Atlas Data Coordination Portal ‘Census of Immune Cells’ project (<ext-link ext-link-type="uri" xlink:href="https://data.humancellatlas.org/explore/projects/cc95ff89-2e68-4a08-a234-480eca21ce79">https://data.humancellatlas.org/explore/projects/cc95ff89-2e68-4a08-a234-480eca21ce79</ext-link>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), human peripheral blood (<xref ref-type="bibr" rid="bib50">Rizzetto et al., 2018</xref>; <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>)<bold>,</bold> and tonsils (<xref ref-type="bibr" rid="bib5">Attaf et al., 2020</xref>; <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>) were used to perform differential expression analysis in which each tissue-specific ASC cluster was compared to its tissue-specific B cell counterpart. A total of 7653, 1079, and 1860 genes were upregulated in ex vivo obtained ASCs from bone marrow, peripheral blood, and tonsils, respectively (<xref ref-type="fig" rid="fig2">Figure 2e–g</xref>). Analysis of the overlap between the identified upregulated genes selected in in vitro and ex vivo data revealed that out of the 1406 upregulated genes found in in vitro-generated ASCs, 1113 (79%) were shared with at least one ex vivo ASC population, of which 349 (25%) were shared with all populations (<xref ref-type="fig" rid="fig2">Figure 2h and i</xref>). The remaining 293 (21%) genes were uniquely upregulated in in vitro-generated ASCs, indicating that these genes might be linked to in vitro culture rather than be general for ASCs. Additionally, ex vivo ASC populations also possess unique differentially expressed genes that are not shared with other ex vivo or in vitro-generated ASC populations (<xref ref-type="fig" rid="fig2">Figure 2i</xref>). These findings indicate that in vivo ASCs carry specific, possibly tissue-related, gene signatures in addition to the ‘core ASC signature’ shared among ASCs. Taken together these data show that the in vitro-generated ASCs have highly similar transcriptional profiles compared to ex vivo-obtained ASCs.</p></sec><sec id="s2-3"><title>A novel B cell to ASC intermediate cellular stage is identified as a precursor of terminally differentiated ASCs</title><p>In our dataset, cells with a prominent ASC gene signature were separated into two distinct transcriptional clusters. The cells in these clusters also show a slightly different expression of the ASCs phenotypic markers CD27 and CD38, with cells in cluster 5 being predominantly CD27<sup>++</sup>CD38<sup>++</sup>, while cluster 4 also includes CD27<sup>-</sup>CD38<sup>+</sup> cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a</xref>). When performing clustering analysis on the dataset without cell-cycle regression, again cells from clusters 4 and 5 separated from the B cells clusters. Interestingly, the two former ASC clusters now separated into two new clusters, whereby the cell cycle stage became the major common denominator between the two clusters (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1j</xref>). This shows that original clusters 4 and 5 contain both cells in the cell cycle and cells that are out of the cell cycle. To further investigate the differences between cells in clusters 4 and 5, the similarity and the enrichment score for ASC gene signature were analyzed for both clusters (<xref ref-type="fig" rid="fig3">Figure 3a and b</xref>). Cells in cluster 4 scored lower than cells in cluster 5 for both ASC similarity and enrichment, indicating a less dominant ASC gene signature in this cluster. Differential expression analysis between clusters 4 and 5 identified a total of 1076 differentially expressed genes, with 114 and 962 genes up- and downregulated in cluster 5, respectively (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). Network analysis of Gene Set Enrichment Analysis (GSEA) results for the differentially expressed genes revealed a predominant enrichment for terms concerning cytoskeleton organization, including supramolecular fiber organization, immune cell receptor signaling, and metabolism of steroids (<xref ref-type="fig" rid="fig3">Figure 3d</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Of note, among the enriched terms concerning cytoskeleton organization, we found ‘<italic>Arp2/3 complex-mediated actin nucleation</italic>,’ recently shown to be important in immune synapses formation (<xref ref-type="bibr" rid="bib11">Bolger-Munro et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Roper et al., 2019</xref>), BCR signaling and B cell activation, together with other terms involved in antigen uptake and processing (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The majority of the processes indicated by the predominantly enriched terms were suppressed in cluster 5 compared to cluster 4, while specifically activated processes in cluster 5 were ‘<italic>protein N-linked glycosylation’</italic> and ‘<italic>retrograde protein transport’</italic> (<xref ref-type="fig" rid="fig3">Figure 3e</xref>). Thus, cells in cluster 4 are still active in antigen presentation and processing, BCR signaling, and fatty acid metabolism, while such processes are being shut down in cells from cluster 5 that conversely upregulate genes involved in protein glycosylation and protein transport.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Pre- and terminally differentiated antibody-secreting cells (ASCs) separated in different clusters.</title><p>(<bold>a</bold>) Uniform Manifold Approximation and Projection (UMAP) projection colored by ASC similarity score (left), along with corresponding distribution of the similar score within each cluster (right). (<bold>b</bold>) Gene Set Enrichment Analysis (GSEA) enrichment plots for ASC gene signature in cells from clusters 4 (left) and 5 (right) compared to the other clusters (NES, normalized enrichment score; FDR, false discovery rate). (<bold>c</bold>) UMAP projection as in <xref ref-type="fig" rid="fig1">Figure 1i</xref> colored by clusters 4 and 5 membership (left) and volcano plot depicting significantly (adjusted p-value&lt;0.05) down- and upregulated genes in cluster 5 compared to cluster 4. (<bold>d</bold>) Functional grouping network diagram of GSEA comparing clusters 4 and 5. The dot size and the dot color represent the number of genes in the pathway and the NES, respectively. (<bold>e</bold>) The top 3 most significantly differentially activated pathways as determined by GO enrichment analysis comparing clusters 4 and 5. The dot size and the dot color represent the number of genes in the pathway and the adjusted p-value, respectively. (<bold>f</bold>) Velocyto force field showing the average differentiation trajectories (velocity) for cells located in different parts of the UMAP plot. Arrow size conveys the strength of predicted directionality. (<bold>g</bold>) PAGA graph showing the connectivity between the clusters. Each node corresponds to each of the clusters identified using Seurat. The most probable path connecting the clusters is plotted with thicker edges. (<bold>h</bold>) UMAP projection of ex vivo B cells and ASC derived from bone marrow, peripheral blood, and tonsil colored by cluster 4 and 5 similarity score.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Enrichment map of Gene Set Enrichment Analysis comparing clusters 4 and 5.</title><p>The dot size and the dot color represent the number of genes in the pathway and the normalized enrichment score (NES), respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To assess whether cluster 4 is a precursor population of cluster 5, we applied two algorithms for analyzing respectively the connectivity and the dynamics between clusters in scRNA-seq datasets, namely, partition-based graph abstraction (PAGA) (<xref ref-type="bibr" rid="bib72">Wolf et al., 2019</xref>) and RNA velocity (<xref ref-type="bibr" rid="bib9">Bergen et al., 2020</xref>). Projection of the RNA velocity vectors on the UMAP representation revealed an area of increased velocity in cluster 4 in the direction of cluster 5, indicating that cells in cluster 4 are rapidly transitioning toward the transcriptomic signature of cells in cluster 5 (<xref ref-type="fig" rid="fig3">Figure 3f</xref>). At the top-right extremity of cluster 5, where most of the non-cycling cells are located, no velocity vectors are projected. This implies that no subsequent cellular stage could be appointed, suggesting an endpoint of differentiation here. In line with this, results of PAGA showed increased connectivity among clusters 4 and 5 (<xref ref-type="fig" rid="fig3">Figure 3g</xref>). Interestingly, only cluster 4 and not cluster 5 was shown to be connected with all three B cell clusters, with cluster 3 being the most pronounced connection followed by cluster 1. This indicates that cluster 4 is more similar to the B cell clusters than cluster 5.</p><p>To confirm that cluster 4 represents a previously overseen intermediate B cell to ASCs population, we obtain a set of hallmark genes for cluster 4 and tested them on the publicly available scRNA-seq dataset from bone marrow, tonsil, and peripheral blood (<xref ref-type="fig" rid="fig3">Figure 3h</xref>). In the bone marrow dataset, the highest similarity score with the cluster 4 hallmark genes was observed in the cells connecting naive B cells to plasma cells. Interestingly, the GC B cells in the tonsil dataset, both non-cycling LZ and cycling DZ GC B cells, showed the highest similarity score with cluster 4 cells, while in the peripheral blood dataset, few cells in the naive/memory cluster showed increased similarity. Of note, when performing the same analysis with the hallmark genes from cluster 5, the highest similarity was observed in each tissue-specific ASC population, as expected.</p><p>Thus, taken together these results show that cluster 5 represents a terminally differentiated ASC population and that cluster 4 represents a novel B cell to ASC intermediate cellular stage, a precursor of terminally differentiated ASCs. This population can also be found ex vivo, mainly in lymphoid tissues with active ASC differentiation.</p></sec><sec id="s2-4"><title>Differentiating B cells transit through a GC-like and early memory phenotype</title><p>To analyze the earlier stage of naive B cell to ASC differentiation, differential expression analysis among the three B cell clusters was performed to identify cluster-specific gene signatures (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Interestingly, genes that mark a GC B cell phenotype, such as <italic>IRF8</italic>, <italic>BCL6</italic>, <italic>CD22,</italic> and <italic>CD83,</italic> were among the top 30 differentially expressed genes in cluster 2 (<xref ref-type="bibr" rid="bib6">Basso and Dalla-Favera, 2010</xref>; <xref ref-type="bibr" rid="bib41">Meyer et al., 2021</xref>; <xref ref-type="bibr" rid="bib67">Victora et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Wang et al., 2019</xref>). When performing GSEA using hallmark gene sets on the differentially expressed genes in cluster 2, MYC (<xref ref-type="bibr" rid="bib15">Calado et al., 2012</xref>; <xref ref-type="bibr" rid="bib19">Dominguez-Sola et al., 2012</xref>) and E2F (<xref ref-type="bibr" rid="bib7">Béguelin et al., 2017</xref>) targets, known to promote GC B cell differentiation, were the top 3 significantly enriched gene sets and, in fact, <italic>MYC</italic> was expressed at its highest in cluster 2 compared to the other clusters (<xref ref-type="fig" rid="fig4">Figure 4b and c</xref>). Finally, the similarity score with ex vivo-sorted human GC B cells was the highest in cluster 2, followed by cluster 3 (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). Thus, we concluded that cells in cluster 2 represent GC-like B cells.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Terminal differentiation into antibody-secreting cells (ASCs) starts from germinal center (GC)-like cells.</title><p>(<bold>a</bold>) Top 30 differentially expressed genes identified in clusters 1–3. The size of the dot encodes the percentage of cells within a cluster, while the color encodes the average gene expression across all cells within a cluster. (<bold>b</bold>) Significantly enriched hallmark gene sets overlapping with the differentially expressed genes identified in cluster 2. (<bold>c</bold>) Uniform Manifold Approximation and Projection (UMAP) projection colored by expression of the transcription factors <italic>MYC</italic> (left), along with corresponding distribution of expression levels (ln(TPM+1)) within each cluster (right). (<bold>d</bold>) Corresponding distribution of the GC similarly score within each cluster (left) and Gene Set Enrichment Analysis (GSEA) enrichment plot (right) for GC B cell gene signature in cells from cluster 2 (NES, normalized enrichment score; FDR, false discovery rate). (<bold>e–k</bold>) UMAP projection colored by expression of the <italic>BANK1</italic> (<bold>e</bold>), <italic>CCR6</italic> (<bold>f</bold>), <italic>MZB1</italic> (<bold>g</bold>), <italic>ITGAX</italic> (<bold>h</bold>), <italic>SIGLEC6</italic> (<bold>i</bold>), <italic>FCRL5</italic> (<bold>j</bold>), <italic>HHEX</italic> (k; left), along with corresponding distribution of expression levels (ln(TPM+1)) within each cluster (right). (<bold>l</bold>) The similarity score of ex vivo germinal center B cell (GC), memory B cell (MBC), and ASC gene sets ordered by UMAP1.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83578-fig4-v2.tif"/></fig><p>For cells in cluster 3, no definite phenotypic signature could be appointed based on the cluster-specific gene signature. However, given the intermediate similarity with both GC B cells and ASC gene signatures (<xref ref-type="fig" rid="fig3">Figures 3a</xref> and <xref ref-type="fig" rid="fig4">4b</xref>) and the higher connectivity indicated by PAGA with the pre-ASCs cluster 4 compared to the other B cell cluster, we hypothesize that cluster 3 might represent a post-GC population primed to become ASCs.</p><p>Among the top differentially expressed genes of cluster 1, we found <italic>BANK1</italic>, recently identified as a marker of a pre-memory B cell stage (<xref ref-type="bibr" rid="bib30">Holmes et al., 2020</xref>) together with <italic>CCR6,</italic> which was also expressed at the highest in cluster 1 (<xref ref-type="fig" rid="fig4">Figure 4e and f</xref>). Of note, <italic>MZB1</italic>, identified in the same study as a marker of pre-ASCs, is expressed at its lowest in cluster 1 (<xref ref-type="fig" rid="fig4">Figure 4g</xref>). Interestingly, <italic>ITGAX</italic> (CD11c) was indicated as differentially expressed in cluster 1 (<xref ref-type="fig" rid="fig4">Figure 4h</xref>). This gene defines a heterogeneous population of, mostly, memory B cells initially discovered in the context of aging and autoimmune disease, called atypical memory B cells or age-associated B cells (ABCs) that are thought to be generated through an alternative extra-follicular pathway (<xref ref-type="bibr" rid="bib59">Sutton et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2018</xref>). Likewise, the expression of other genes associated with the CD11c<sup>+</sup> phenotype, such as <italic>SIGLEC6</italic> and <italic>FCRL5</italic>, was increased in cluster 1 (<xref ref-type="fig" rid="fig4">Figure 4i and j</xref>) while <italic>CR2</italic> (CD21), <italic>TBX21</italic> (T-bet), <italic>FCRL4,</italic> and <italic>CXCR3</italic> were not expressed in our dataset (data not shown). Finally, <italic>HHEX</italic>, recently shown to direct B cells away from the GC reaction into memory differentiation (<xref ref-type="bibr" rid="bib35">Laidlaw et al., 2020</xref>), was also increased in cluster 1 (<xref ref-type="fig" rid="fig4">Figure 4k</xref>). Together, these data suggest that cells in cluster 1 are committed to becoming memory B cells.</p><p>To confirm the above findings of an in vitro B differentiation system in which GC-like B cells are directed toward both a memory and an ASCs cell phenotype, we analyzed the similarity score of all cells in our dataset ordered based on UMAP1 with gene signatures obtained from ex vivo-sorted B cell at different differentiation stages, namely, GC B cell, memory B cells ,and ASCs (<xref ref-type="fig" rid="fig4">Figure 4l</xref>). As expected, the ASCs similarity score increases following UMAP1-based differentiation, starting at the lowest in cluster 2 and gradually increasing going through clusters 3–5. Conversely, the similarity with GC B cell starts at the highest in cluster 2 and rapidly decreases going toward cluster 1; a slight stagnation is then observed in correspondence to cluster 3, followed by an additional decrease going through clusters 4 and 5. Finally, the similarity with memory B cells starts low with cluster 2, picks up in cluster 1, and decreases again through clusters 3–5. Thus, the differentiation dynamics observed in our in vitro system recapitulate ex vivo naive B cell differentiation processes, including both a memory and an ASC differentiation route.</p><p>To conclude, these results indicate that B cells with a GC-like phenotype are identified in vitro from human naive B cells after culture in the presence of IL-4 and IL-21, and CD40L costimulation. Additionally, we find a post-GC B cell population with increased connectivity to the novel B cell to ASCs intermediate and a B cell population with a memory-like phenotype.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we set out to elucidate different stages of naive human B cell differentiation into ASCs by performing single-cell transcriptomics, B cell receptor reconstruction, and trajectory inference analysis on in vitro-differentiated human naive B cells and integrating these data with ex vivo transcriptomes of isolated B cells and ASC subsets derived from different human tissues. We demonstrated that the in vitro-generated ASC are highly comparable to ex vivo ASCs. This led to the identification of a B cell to ASCs intermediate population still active in antigen presentation and processing that shows transcriptional similarity to B cell populations found ex vivo in lymphoid tissue with active ASCs differentiation processes (like tonsils) and phenotypic resemblance (i.e., intermediate CD27 and CD38 expression, lower expression of <italic>PRDM1</italic>, and higher expression of <italic>PAX5</italic> compared to CD138 plasma blasts) to a pre-ASC population recently identified in the peripheral blood of healthy individuals 6 days post-vaccination (<xref ref-type="bibr" rid="bib55">Sanz et al., 2019</xref>). This population might therefore represent a previously overseen B cell to ASCs intermediate that is challenging to identify in normal steady-state conditions as it only appears transiently during ASC formation. Finally, B cells with a GC-like and a pre-memory phenotype were identified in our in vitro system, thus recapitulating the different naive B differentiation processes observed in vivo.</p><p>To the best of our knowledge, this is the first study in which GC-like B cells are identified in vitro from human naive B cells. While a similar culture system is well-established and commonly used in mouse B cell biology (<xref ref-type="bibr" rid="bib27">Gonzalez et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Nojima et al., 2011</xref>), studies utilizing human B cells are limited in comparison. This finding could help us to decode one important and still unanswered question in B cell biology, that is, which factors control the decisions for a GC-B cell to differentiate into a memory B cell or a plasma cell (<xref ref-type="bibr" rid="bib1">Akkaya et al., 2020</xref>). In our system, we were able to clearly define cells with an ASCs phenotype (clusters 4 and 5) and cells with a gene signature that pointed toward a memory-like B cell phenotype (cluster 1). Surprisingly, the fact that both analyses focused on connection and dynamics between clusters, that is, PAGA and RNA velocity, did not indicate a direct strong connection between the B cells clusters and the ASCs clusters raises the question of whether these two populations are related. In this respect, the in vitro-generated ASCs could be differentiating from a cell population that is lost at the time of our analysis or independently of a GC reaction. Additional research including time-course experiments is needed to further explore this possibility.</p><p>In line with this, the higher connectivity observed among the three B cell clusters rather than with the ASCs cluster could indicate the presence of an alternative differentiation wave <italic>in time</italic>. In fact, the GC B cells of cluster 2 might represent the next GC reaction after the one that gave rise to the ASCs of clusters 4 and 5, and that would have generated new ASCs, possibly from cluster 3 if the culture would not be interrupted for analysis. This hypothesis raises the intriguing question of whether the memory cells of cluster 1 are again an alternative end point or the starting point of this second GC reaction. Unfortunately, this is bioinformatically difficult to rule out as currents methods to infer cellular trajectory do require a priori knowledge of the start point of differentiation (<xref ref-type="bibr" rid="bib52">Saelens et al., 2019</xref>), while unbiased analysis of cellular stage transition, such as RNA velocity, can still not be corrected for possible other drivers of cellular stage transition such as cell cycle (<xref ref-type="bibr" rid="bib10">Bergen et al., 2021</xref>).</p><p>A concept that is now supported by several studies is that different levels of antigen-affinity and different timing of generation during the GC reaction dictate the fate of a GC B cell to become either a memory B cell or a long-lived plasma cell (<xref ref-type="bibr" rid="bib56">Smith et al., 1997</xref>; <xref ref-type="bibr" rid="bib71">Weisel et al., 2016</xref>). Memory B cells that arise from GC reactions are an earlier output in the GC reaction than plasma cells and therefore accumulate somewhat less (albeit is mostly still considerable) affinity-increasing SHM (<xref ref-type="bibr" rid="bib71">Weisel et al., 2016</xref>). Conversely, long-lived plasma cells are generated at a later stage of the GC reaction and are equipped with highly affine and highly mutated BCRs. Additionally, mouse studies have highlighted the role of Tfh-produced cytokines such as IL-21 and IL-4 in respectively inducing long-lived plasma cells or memory B cells upon in vivo transfer of in vitro-induced GC-like B cells (<xref ref-type="bibr" rid="bib45">Nojima et al., 2011</xref>). In our in vitro system, IL-21 and IL-4 are provided together, explaining the possibility of having both plasma cell and memory populations at the end of the culture. It would be interesting to further analyze the output of a culture in which only one of the cytokines is provided, and in particular, if the presence of IL-4 only could boost the memory population as already demonstrated in vivo in mice (<xref ref-type="bibr" rid="bib21">Duan et al., 2021</xref>). Furthermore, in vitro mouse studies demonstrated that naive B cells need to be primed in culture with IL-4 to obtain the GC-like phenotype and that naive B cells cultured directly in presence of IL-21 proliferate less and directly differentiate into ASCs. Whether the directly generated ASCs are identical to the ASCs generated via the GC-like intermediate stage still needs to be further investigated.</p><p>Interestingly, the metabolism of steroids and cholesterol were among the most enriched terms for the differentially expressed genes between the pre- and terminally differentiated ASCs. This is in line with the concept that the full commitment to antibody production and secretion of terminally differentiated ASCs requires a massive reprogramming of the metabolism not only to provide the molecular ‘bricks’ for antibody production, that is, amino acids and sugars, but also the cellular machinery to sustain such massive production,that is, ER and Golgi expansion. In this respect, several studies demonstrated that the de novo synthesis of fatty acid is a crucial step in plasma cell formation (<xref ref-type="bibr" rid="bib22">Dufort et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Fagone et al., 2007</xref>). Additionally, some new pieces of evidence support the hypothesis that antibody secretion and ER stress might be linked to the longevity of plasma cells (<xref ref-type="bibr" rid="bib26">Goldfinger et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Pengo et al., 2013</xref>). In future studies, we shall focus on the analysis of the changes in metabolic pathways that occur in our in vitro systems. A deeper analysis of the metabolic reprogramming happening at the interchange between the different cellular stages observed in our in vitro system might reveal that metabolism plays an additional layer of control on top of the known transcriptional ones for B cell differentiation.</p><p>To conclude, using an in vitro system that accurately recapitulates the in vivo human GC reaction we uncovered a novel intermediate population in the ASC differentiation process and possibly an alternative route of differentiation into memory B cells. Further research is needed to further dissect the regulation of human B cell differentiation processes and in particular the choice between the two differentiation routes in both healthy and diseased conditions.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Cell culture</title><p>NIH3T3 WT fibroblast cells (3T3) and human CD40L-expressing 3T3 (<xref ref-type="bibr" rid="bib65">Urashima et al., 1996</xref>) were cultured in IMDM (Lonza) containing 10% FCS (Bodinco), 100 U/ml penicillin (Invitrogen), 100 μg/ml streptomycin (Invitrogen), 2 mM L-glutamine (Invitrogen), 50 μM β-mercaptoethanol (Sigma-Aldrich), and 500 μg/ml G418 (Life Technologies).</p></sec><sec id="s4-2"><title>Isolation of peripheral blood B cells from human healthy donors</title><p>Buffy coats of healthy human donors were obtained from Sanquin Blood Supply. All healthy donors provided written informed consent following the protocol of the local institutional review board, the Medical Ethics Committee of Sanquin Blood Supply, and conforms to the principles of the Declaration of Helsinki. PBMCs were isolated from buffy coats using a Lymphoprep (Axis-Shield PoC AS) density gradient. Afterward, CD19<sup>+</sup> B cells were separated using magnetic Dynabeads (Invitrogen) according to the manufacturer’s instructions.</p></sec><sec id="s4-3"><title>In vitro naive B cell differentiation cultures</title><p>CD40L-expressing 3T3 cells were harvested, irradiated with 30 Gy, and 1 × 10<sup>4</sup> CD40L-expressing 3T3 cells were seeded in B cell medium (RPMI 1640 [Gibco] without phenol red containing 5% FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine, 50 μM β-mercaptoethanol, and 20 μg/ml human apotransferrin [Sigma-Aldrich; depleted for human IgG with protein G sepharose]) in 96-well flat-bottom plates (NUNC) to allow adherence overnight. The next day, 2.5 × 10<sup>4</sup> human naive (CD19<sup>+</sup>CD27<sup>-</sup>IgG<sup>-</sup>IgD<sup>+</sup>) B cells were sorted on a FACS Aria and activated using the irradiated CD40L-expressing 3T3 cells in the presence of IL-4 (100 ng/ml; CellGenix) for 6 days.</p><p>After 6 days, activated B cells were collected and co-cultured with 1 × 10<sup>4</sup> 9:1 WT 3T3 to CD40L-expressing 3T3 cells that were irradiated and seeded 1 day in advance (as described above), together with IL-4 (100 ng/ml) and IL-21 (50 ng/ml; Invitrogen) for 5 days.</p></sec><sec id="s4-4"><title>Flow cytometry and sorting</title><p>Cells were first washed with PBS and stained with LIVE/DEAD Fixable Near-IR (Dead cell stain kit, Invitrogen) for 30 min at room temperature in the dark. Then, cells were washed with PBS supplemented with 1% bovine serum albumin. Extracellular staining was performed by incubating the cells for 30 min on ice in the dark with the following antibodies: anti-CD19 (clone SJ25-C1, BD Biosciences), anti-CD27 (clone L128, BD Biosciences; clone O323, eBioscience), anti-CD38 (clone HB7, BD Biosciences), anti-CD138 (clone MI15; BD Biosciences), and anti-IgG (clone G18-145, BD Biosciences; clone MH16-1, Sanquin Reagents). Samples were measured on LSRII and analyzed using FlowJo software (Treestar).</p><p>For FACS sorting for single-cell RNA sequencing, samples were stained as described previously with LIVE/DEAD Fixable Near-IR (Invitrogen) and the following antibodies: anti-CD19 (clone SJ25-C1, BD Biosciences), anti-CD27 (clone O323, eBioscience), anti-CD38 (clone HB7, BD Biosciences), and anti-CD138 (clone MI15; BD Biosciences). Sorting was performed on Aria IIIu with FACSDiva software v7 optimized for indexed cell sorting. Single cells were sorted by gating CD27/CD38 subpopulations of the living cell compartment. Cells were sorted in 384-well twin.tec plates (Eppendorf) containing 2.3 μl of lysis buffer per well. Lysis buffer consisted of 2.5 μM oligo-dT30 VN primers, 2.5 μM dNTP mix, 0.2% Triton X-100, and 1 U RNase inhibitor. After sorting, plates were centrifuged, snap-frozen on dry ice, and stored at –80°C until further processing.</p></sec><sec id="s4-5"><title>Real-time semi-quantitative RT-PCR</title><p>Different B-cell subsets (as indicated) were sorted. After sorting, RT–PCR was performed as described before (<xref ref-type="bibr" rid="bib58">Souwer et al., 2009</xref>). Primers were developed to span exon-intron junctions and then validated (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Gene expression levels were measured in duplicate reactions for each sample in StepOnePlus (Applied Biosystems, Foster City, CA) using the SYBR green method (Applied Biosystems).</p></sec><sec id="s4-6"><title>CRISPR–Cas9-mediated gene deletion of primary B cells</title><p>CRISPR-targeting RNA (crRNAs) were designed with the InDelphi (<ext-link ext-link-type="uri" xlink:href="https://indelphi.giffordlab.mit.edu">https://indelphi.giffordlab.mit.edu</ext-link>), benchling (<ext-link ext-link-type="uri" xlink:href="https://www.benchling.com">https://www.benchling.com</ext-link>), and Integrated DNA Technologies design tools (<ext-link ext-link-type="uri" xlink:href="http://www.idtdna.com">http://www.idtdna.com</ext-link>). Designed crRNAs were synthesized by Integrated DNA Technologies as Alt-R CRISPR/Cas9 crRNAs. crRNA sequences used in the study were as follows: crCD19, 5′-<named-content content-type="sequence">TCCCTCGGTGGGAGACACGG</named-content>-3′; crPRDM1#1, 5′-<named-content content-type="sequence">CATTAAAGCCGTCAATGAAG</named-content>-3′; crPRDM1#2, 5′-<named-content content-type="sequence">TGCTCCCGGGGAGAGTGTGC</named-content>-3′; crPRDM1#3, 5′- <named-content content-type="sequence">GAAGTGGTGAAGCTCCCCTC</named-content>-3′.</p><p>crRNA and trans-activating CRISPR RNA (tracrRNA; Integrated DNA Technologies) were duplexed by heating at 95°C for 5 min. crRNA–tracrRNA duplexes were mixed with Cas9 protein (TrueCut v2; Thermo Fisher) for 10 min at room temperature to form stable ribonucleoprotein (RNP) complexes. 2.5 × 10<sup>4</sup> primary human naive (CD19<sup>+</sup>CD27<sup>-</sup>IgG<sup>-</sup>IgD<sup>+</sup>) B cells were activated for 3 days with 1 × 10<sup>4</sup> irradiated CD40L-expressing 3T3 cells in the presence of IL-21 (50 ng/ml). After 3 days, cells were harvested and resuspended in P3 buffer (Lonza), mixed with RNP complexes, added to nucleofector cuvettes (Lonza), and electroporated with Amaxa 4D Nucleofector (Lonza) using program EH-115. Activated and electroporated B cells were then resuspended in a pre-warmed B cell medium and 2.5 × 10<sup>4</sup> cells were plated in wells pre-seeded with 1 × 10<sup>4</sup> irradiated CD40L-expressing 3T3 cells in the presence of IL-21 (50 ng/ml). After 3 days, B cells were harvested and put on freshly irradiated CD40L-expressing 3T3 cells in the presence of IL-21 (50 ng/ml) for 5 days.</p></sec><sec id="s4-7"><title>Preparation of cDNA libraries and sequencing</title><p>Sorted cells were processed using the Smart-seq2 protocol (<xref ref-type="bibr" rid="bib47">Picelli et al., 2014</xref>) adjusted for 384-well plates. In short, 384-well plates containing single cells were thawed and cells were lysed and mRNA denatured by incubating the plates at 95°C for 3 min and put back on ice. Subsequently, 2.7 μl of first-strand cDNA reagent mix, containing 1x first-strand buffer, 5 mM DTT, 1 M betaine, 14 mM MgCl<sub>2</sub>, 5U RNase inhibitor, 25U Superscript II Reverse Transcriptase, and 1 μM Template-Switching oligonucleotides in nuclease-free water, was added to each well. Plates were incubated at 42°C for 90 min, 70°C for 15 min, and kept on hold at 4°C. Afterward, 7.5 μl of the pre-amplification mix, consisting of 1x KAPA HiFi HotStart Readymix and 0.12 μM ISPCR primers in nuclease-free water, was added to each well. Plates were then incubated as followed: 98°C for 3 min, 23 cycles of 98°C for 20 s; 67°C for 15 s; and 72°C for 6 min, then at 72°C for 5 min and kept on hold at 4°C. Purification of the resulting cDNA was performed using SeraMag SpeedBeads containing 19% w/v PEG 8,000 and a 1:0.8 ratio of cDNA/beads was used for cDNA precipitation. Purified cDNA was eluted in 14 μl of nuclease-free water. The quality of cDNA was randomly checked in 5% of the wells using the Tapestation High-Sensitivity D5000 assay. For the tagmentation reaction, 0.5 μl of 50–150 pg cDNA was mixed with a 1.5 μl Tagmentation mix containing 1x Tagment DNA buffer and Amplicon Tagment mix (Nextera XT DNA sample preparation kit). Plates were incubated at 55°C for 8 min and kept on hold at 4°C. 0.5 μl Neutralize Tagment buffer was added and incubated at room temperature for 5 min to inactivate Tn5. PCR amplification of adapter-ligated cDNA fragments was performed in a final volume of 5 μl containing the two index primers (Nextera XT Index kit) in a 1:5 dilution and Nextera PCR master mix. Plates were then incubated as follows: 72°C for 3 min, 95°C for 30 s, then 14–15 cycles of 95°C for 10 s; 55°C for 30 s; and 72°C for 30 s, then 72°C for 5 min and kept on hold at 4°C. 384 wells (the entire plate, including negative controls) were pooled in a single 2 ml tube (Eppendorf). Purification of cDNA was performed by adding 400 μl of cDNA in a 1:1 ratio with SeraMag SpeedBeads in 19% w/v PEG 8000 in a 1.5 ml LoBind tube. Beads were washed with 1 ml of 80% ethanol. Purified cDNA was eluted in 200 μl of nuclease-free water. The concentration of the library was measured by Qubit according to the manufacturer’s instructions. The size distribution of the library was measured using the Tapestation High-Sensitivity D1000 or D5000 assay. The cDNA library pool was stored at –20°C until ready for sequencing.</p><p>cDNA library pool was diluted to 2 nM and prepared for sequencing using the NextSeq 500 High Output Kit v2 (75 cycles) according to the manufacturer’s instructions. Sequencing was performed on an Illumina NextSeq 500 instrument.</p></sec><sec id="s4-8"><title>Preprocessing of single-cell RNA sequencing data</title><p>The quality of the retrieved sequencing data was assessed using FastQC (<xref ref-type="bibr" rid="bib4">Andrews, 2010</xref>). Reads were pseudo-aligned to the human transcriptome (gencode version v27) using kallisto (<xref ref-type="bibr" rid="bib12">Bray et al., 2016</xref>). Quantification of gene expression was obtained by gene-level summarization of transcripts abundance using the R package tximport (<xref ref-type="bibr" rid="bib57">Soneson et al., 2015</xref>), without any scaling (countsFromAbundance option set to ‘no’). Counts were then normalized using the transcript per million (TPM) method (<xref ref-type="bibr" rid="bib36">Li et al., 2010</xref>) with the following approach: (a) gene length scaling, (b) removal of all immunoglobulins genes and pseudogenes, and (c) sequencing depth scaling (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). Removal of immunoglobulin genes at this stage prevented the artificial skewing of other genes expressed in the ASC clusters due to the high content of immunoglobulins RNA present in this cell type. The scaled TPM matrix was used for downstream analysis.</p></sec><sec id="s4-9"><title>Single-cell RNA sequencing data analysis</title><p>Gene expression was analyzed using the Seurat package in R (<xref ref-type="bibr" rid="bib29">Hao et al., 2021</xref>). The scaled TPM matrix and metadata information were used to create a Seurat object with the following specifications: min.cell=3, min.feature=200. Putative low-quality cells and doublets were removed based on the distribution of genes per cell (<xref ref-type="bibr" rid="bib14">Butler et al., 2018</xref>). Cells were then checked for alignment to the human genome (GRCh38) and the fraction of mitochondrial genes as a measure of cell stress. Quality control criteria for cell exclusion were set as follows: percentage of mitochondrial genes &gt;20%, percentage of aligned reads &lt;60%, and the number of total genes expressed within 5000 and 10,000 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b and c</xref>). A total of 276 cells passed quality control and did not affect the distribution of the four CD27/38 populations, indicating that all populations were of equal quality, and could be used for further analysis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d</xref>). Gene expression values were then transformed to log2 TPM+1 and these values were used for all downstream analyses. Before performing dimensional reduction, the <italic>FindVariableFeatures</italic> function was applied to retrieve the top 2000 high variable genes followed by a global data scaling using the <italic>ScaleData</italic> function. Principal component analysis (PCA) was chosen as a linear dimensionality reduction technique using the previously selected 2000 high variable genes as input and allowing 50 components. PCA-based cell clustering was performed by applying the <italic>FindNeighbors</italic> function on the first 10 PCAs followed by the <italic>FindClusters</italic> function with 0.5 resolution and the Leiden algorithm. For visualization purposes, a second nonlinear dimensionality reduction was performed using the <italic>RunUMAP</italic> function on the first 10 PCAs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1e</xref>).</p></sec><sec id="s4-10"><title>Differential expression analysis</title><p>Differential expression analysis was performed on all genes using the wilcoxauc method from <italic>presto</italic> (<xref ref-type="bibr" rid="bib34">Korsunsky et al., 2019</xref>). GSEA was performed using the <italic>clusterProfiler</italic> package in R on 17,716 genes ranked based on logFC * adjusted p-value using the Gene Ontology (GO) and the hallmark human gene sets obtained from MsigDB4 (<xref ref-type="bibr" rid="bib37">Liberzon et al., 2015</xref>). For visualization, hierarchical clustering of GSEA results was performed using the <italic>pairwise_termsim</italic> function from <italic>enrichplot</italic> with an adjusted p-value&lt;0.05 and then plotted using the <italic>emapplot</italic> function.</p></sec><sec id="s4-11"><title>Publicly available (sc)RNAseq datasets</title><p>For the analysis of the publicly available scRNA-seq dataset of B cells from different human tissues (<xref ref-type="bibr" rid="bib5">Attaf et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Jardine et al., 2021</xref>; <xref ref-type="bibr" rid="bib50">Rizzetto et al., 2018</xref>), processed gene expression matrixes were downloaded and cells were annotated as provided by the authors. For similarity and enrichment score analyses, the publicly available genes set GSE12366 that includes gene sets from up- and downregulated genes found in sorted naive B cells, memory B cells, GC B cells, and plasma cells were used (<xref ref-type="bibr" rid="bib40">Longo et al., 2009</xref>). The similarity score was then calculated using <italic>AddModuleScore</italic> from Seurat. For the analysis of similarity score over differentiation as reported in <xref ref-type="fig" rid="fig4">Figure 4l</xref>, the upregulated gene sets were compared and genes that were uniquely expressed by one population were used to calculate the similarity score to that population.</p></sec><sec id="s4-12"><title>Trajectory inference</title><p>Pseudotemporal ordering of the differentiating B cells trajectory, a PAGA (<xref ref-type="bibr" rid="bib72">Wolf et al., 2019</xref>) was performed for the transcriptionally distinct cell clusters using the tl.paga function in <italic>scanpy</italic>. Velocity-based pseudotime reconstruction was performed using RNA velocity. To obtain the spliced and unspliced matrix for RNA velocity analysis, original fastq files were re-aligned using STAR (v2.7.7). Obtained.sam files were converted to sorted.bam files using <italic>samtools</italic> (v1.11). Sorted.bam files were fed into <italic>velocyto</italic> (v0.17.17) using the run-smartseq2 option. The obtained <italic>loom</italic> file containing the spliced and unspliced count matrix was imported into python and then merged with the Seurat object after conversion to <italic>annData</italic> format (<italic>convertFormat</italic> function from the <italic>sceasy</italic> R package). RNA velocity analysis was then performed using the <italic>scVelo</italic> (v0.2.2) package in python.</p></sec><sec id="s4-13"><title>B cell receptor analysis</title><p>Reconstruction of the rearranged B cell receptor sequences was performed using BraCeR (<xref ref-type="bibr" rid="bib38">Lindeman et al., 2018</xref>) on the cells that passed quality control. The functions <italic>assemble</italic> and <italic>summarise</italic> were run to obtain respectively all possible BCR rearrangements and only the functional BCR rearrangements per cell. For every cell, one functional heavy chain and one functional light-chain BCR rearrangements were selected based on the highest expression. These sequences were then submitted to the HighV-quest portal of the International ImMunoGeneTics information system website (<ext-link ext-link-type="uri" xlink:href="http://www.imgt.org">http://www.imgt.org</ext-link>) for further BCR characterization. Further analysis of the BCR rearrangements was performed using the tools from the Immcantation portal (<ext-link ext-link-type="uri" xlink:href="https://immcantation.readthedocs.io/en/stable/">https://immcantation.readthedocs.io/en/stable/</ext-link>). In particular, <italic>Change-O</italic> was used to perform clonal clustering and <italic>Alakazam</italic> was used for the analysis of somatic hypermutation.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Designed the experiments</p></fn><fn fn-type="con" id="con2"><p>Designed the experiments</p></fn><fn fn-type="con" id="con3"><p>Designed the experiments</p></fn><fn fn-type="con" id="con4"><p>Performed the experiments</p></fn><fn fn-type="con" id="con5"><p>Analyzed the data</p></fn><fn fn-type="con" id="con6"><p>Performed the experiments</p></fn><fn fn-type="con" id="con7"><p>Performed the experiments</p></fn><fn fn-type="con" id="con8"><p>Provided intellectual input to the study</p></fn><fn fn-type="con" id="con9"><p>Provided intellectual input to the study</p></fn><fn fn-type="con" id="con10"><p>Provided intellectual input to the study</p></fn><fn fn-type="con" id="con11"><p>Provided intellectual input to the study</p></fn><fn fn-type="con" id="con12"><p>Supervised the study</p></fn><fn fn-type="con" id="con13"><p>Supervised the study</p></fn><fn fn-type="con" id="con14"><p>Conceived the study</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All the healthy donors provided written informed consent following the protocol of the local institutional review board, the Medical Ethics Committee of Sanquin Blood Supply, and conforms to the principles of the Declaration of Helsinki.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-83578-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primer sequences.</title></caption><media xlink:href="elife-83578-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All raw fastq files and digital gene expression matrixes (DGE) are available at the Gene Expression Omnibus (GEO) repository under accession no. GSE214265.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Pollastro</surname><given-names>S</given-names></name><name><surname>Unger</surname><given-names>PA</given-names></name><name><surname>Marsman</surname><given-names>C</given-names></name><name><surname>Elias</surname><given-names>G</given-names></name><name><surname>Jorritsma</surname><given-names>T</given-names></name><name><surname>Streutker</surname><given-names>M</given-names></name><name><surname>Baβler</surname><given-names>K</given-names></name><name><surname>Händler</surname><given-names>K</given-names></name><name><surname>Rispens</surname><given-names>T</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>ten Brinke</surname><given-names>A</given-names></name><name><surname>Beyer</surname><given-names>M</given-names></name><name><surname>van Ham</surname><given-names>SM</given-names></name><collab>NJMC Verstegen</collab></person-group><year iso-8601-date="2022">2022</year><data-title>Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE214265">GSE214265</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>NS</given-names></name><name><surname>Lugar</surname><given-names>PL</given-names></name><name><surname>Yavuz</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Krijger</surname><given-names>PHL</given-names></name><name><surname>Russ</surname><given-names>DE</given-names></name><name><surname>Jima</surname><given-names>DD</given-names></name><name><surname>Dave</surname><given-names>SS</given-names></name><name><surname>Grammer</surname><given-names>AC</given-names></name><name><surname>Lipsky</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2009">2009</year><data-title>Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12366">GSE12366</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Goh</surname><given-names>I</given-names></name><name><surname>Quiroga Londoño</surname><given-names>M</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Mather</surname><given-names>M</given-names></name><name><surname>Olabi</surname><given-names>B</given-names></name><name><surname>Stephenson</surname><given-names>E</given-names></name><name><surname>Botting</surname><given-names>RA</given-names></name><name><surname>Horsfall</surname><given-names>D</given-names></name><name><surname>Engelbert</surname><given-names>J</given-names></name><name><surname>Maunder</surname><given-names>D</given-names></name><name><surname>Mende</surname><given-names>N</given-names></name><name><surname>Murnane</surname><given-names>C</given-names></name><name><surname>Dann</surname><given-names>E</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>H</given-names></name><name><surname>Kucinski</surname><given-names>I</given-names></name><name><surname>Queen</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>CD</given-names></name><name><surname>Shrubsole</surname><given-names>C</given-names></name><name><surname>Poyner</surname><given-names>E</given-names></name><name><surname>Acres</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Ness</surname><given-names>T</given-names></name><name><surname>Coulthard</surname><given-names>R</given-names></name><name><surname>Elliott</surname><given-names>N</given-names></name><name><surname>O'Byrne</surname><given-names>S</given-names></name><name><surname>Haltalli</surname><given-names>MLR</given-names></name><name><surname>Lawrence</surname><given-names>JE</given-names></name><name><surname>Lisgo</surname><given-names>S</given-names></name><name><surname>Balogh</surname><given-names>P</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>Prigmore</surname><given-names>E</given-names></name><name><surname>Ambridge</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>MS</given-names></name><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Pickard</surname><given-names>K</given-names></name><name><surname>Creasey</surname><given-names>T</given-names></name><name><surname>Bacardit</surname><given-names>J</given-names></name><name><surname>Henderson</surname><given-names>D</given-names></name><name><surname>Coxhead</surname><given-names>J</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Hussain</surname><given-names>R</given-names></name><name><surname>Dixon</surname><given-names>D</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Popescu</surname><given-names>DM</given-names></name><name><surname>Kowalczyk</surname><given-names>MS</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Ashenberg</surname><given-names>O</given-names></name><name><surname>Tabaka</surname><given-names>M</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Tickle</surname><given-names>TL</given-names></name><name><surname>Slyper</surname><given-names>M</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>NK</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Roberts</surname><given-names>I</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Blood and immune development in human fetal bone marrow and Down syndrome</data-title><source>Metadata and matrices</source><pub-id pub-id-type="accession" xlink:href="https://data.humancellatlas.org/explore/projects/cc95ff89-2e68-4a08-a234-480eca21ce79">cc95ff89-2e68-4a08-a234-480eca21ce79</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Attaf</surname><given-names>N</given-names></name><name><surname>Cervera-Marzal</surname><given-names>I</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Renand</surname><given-names>A</given-names></name><name><surname>Spinelli</surname><given-names>L</given-names></name><name><surname>Milpied</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>FB5P-seq: FACS-based 5-prime end single-cell RNAseq for integrative analysis of transcriptome and antigen receptor repertoire in B and T cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137275">GSE137275</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Rizzetto</surname><given-names>S</given-names></name><name><surname>Koppstein</surname><given-names>DNP</given-names></name><name><surname>Samir</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Reed</surname><given-names>JH</given-names></name><name><surname>Cai</surname><given-names>CH</given-names></name><name><surname>Lloyd</surname><given-names>AR</given-names></name><name><surname>Eltahla</surname><given-names>AA</given-names></name><name><surname>Goodnow</surname><given-names>CC</given-names></name><name><surname>Luciani</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>B-cell receptor reconstruction from single-cell RNA-seq with VDJPuzzle</data-title><source>Metadata and matrices</source><pub-id pub-id-type="accession" xlink:href="https://bitbucket.org/kirbyvisp/vdjpuzzle2">vdjpuzzle2</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the core facility at Sanquin, Erik Mul, Simon Tol, and Mark Hoogenboezem, for providing technical assistance. This research project was supported by a Landsteiner Foundation for Blood Transfusion Research grant (LSBR 1609) and a Product and process development grant for cellular products by Sanquin (PPOC17-34/L2263). MB was supported by the German Research Foundation (IRTG2168-272482170, SFB1454-432325352).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akkaya</surname><given-names>M</given-names></name><name><surname>Kwak</surname><given-names>K</given-names></name><name><surname>Pierce</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>B cell memory: building two walls of protection against pathogens</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0244-2</pub-id><pub-id pub-id-type="pmid">31836872</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti-Servera</surname><given-names>L</given-names></name><name><surname>von Muenchow</surname><given-names>L</given-names></name><name><surname>Tsapogas</surname><given-names>P</given-names></name><name><surname>Capoferri</surname><given-names>G</given-names></name><name><surname>Eschbach</surname><given-names>K</given-names></name><name><surname>Beisel</surname><given-names>C</given-names></name><name><surname>Ceredig</surname><given-names>R</given-names></name><name><surname>Ivanek</surname><given-names>R</given-names></name><name><surname>Rolink</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Cell RNA sequencing reveals developmental heterogeneity among early lymphoid progenitors</article-title><source>The EMBO Journal</source><volume>36</volume><fpage>3619</fpage><lpage>3633</lpage><pub-id pub-id-type="doi">10.15252/embj.201797105</pub-id><pub-id pub-id-type="pmid">29030486</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andor</surname><given-names>N</given-names></name><name><surname>Simonds</surname><given-names>EF</given-names></name><name><surname>Czerwinski</surname><given-names>DK</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Grimes</surname><given-names>SM</given-names></name><name><surname>Wood-Bouwens</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Kubit</surname><given-names>MA</given-names></name><name><surname>Greer</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>WA</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell RNA-seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints</article-title><source>Blood</source><volume>133</volume><fpage>1119</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1182/blood-2018-08-862292</pub-id><pub-id pub-id-type="pmid">30591526</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><data-title>FastQC: a quality control tool for high throughput sequence data</data-title><source>FastQC</source><ext-link ext-link-type="uri" xlink:href="https://bioinformatics.babraham.ac.uk/projects/fastqc/">https://bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attaf</surname><given-names>N</given-names></name><name><surname>Cervera-Marzal</surname><given-names>I</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Renand</surname><given-names>A</given-names></name><name><surname>Spinelli</surname><given-names>L</given-names></name><name><surname>Milpied</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>FB5P-seq: FACS-based 5-prime end single-cell RNA-seq for integrative analysis of transcriptome and antigen receptor repertoire in B and T cells</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>216</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00216</pub-id><pub-id pub-id-type="pmid">32194545</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>K</given-names></name><name><surname>Dalla-Favera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis</article-title><source>Advances in Immunology</source><volume>105</volume><fpage>193</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/S0065-2776(10)05007-8</pub-id><pub-id pub-id-type="pmid">20510734</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Béguelin</surname><given-names>W</given-names></name><name><surname>Rivas</surname><given-names>MA</given-names></name><name><surname>Calvo Fernández</surname><given-names>MT</given-names></name><name><surname>Teater</surname><given-names>M</given-names></name><name><surname>Purwada</surname><given-names>A</given-names></name><name><surname>Redmond</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Challman</surname><given-names>MF</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Melnick</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an rb-E2F1 feedback loop</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>877</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01029-x</pub-id><pub-id pub-id-type="pmid">29026085</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belnoue</surname><given-names>E</given-names></name><name><surname>Pihlgren</surname><given-names>M</given-names></name><name><surname>McGaha</surname><given-names>TL</given-names></name><name><surname>Tougne</surname><given-names>C</given-names></name><name><surname>Rochat</surname><given-names>AF</given-names></name><name><surname>Bossen</surname><given-names>C</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>Huard</surname><given-names>B</given-names></name><name><surname>Lambert</surname><given-names>PH</given-names></name><name><surname>Siegrist</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells</article-title><source>Blood</source><volume>111</volume><fpage>2755</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-09-110858</pub-id><pub-id pub-id-type="pmid">18180376</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergen</surname><given-names>V</given-names></name><name><surname>Lange</surname><given-names>M</given-names></name><name><surname>Peidli</surname><given-names>S</given-names></name><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Generalizing RNA velocity to transient cell states through dynamical modeling</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>1408</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0591-3</pub-id><pub-id pub-id-type="pmid">32747759</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergen</surname><given-names>V</given-names></name><name><surname>Soldatov</surname><given-names>RA</given-names></name><name><surname>Kharchenko</surname><given-names>PV</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>RNA velocity-current challenges and future perspectives</article-title><source>Molecular Systems Biology</source><volume>17</volume><elocation-id>e10282</elocation-id><pub-id pub-id-type="doi">10.15252/msb.202110282</pub-id><pub-id pub-id-type="pmid">34435732</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger-Munro</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>K</given-names></name><name><surname>Scurll</surname><given-names>JM</given-names></name><name><surname>Abraham</surname><given-names>L</given-names></name><name><surname>Chappell</surname><given-names>RS</given-names></name><name><surname>Sheen</surname><given-names>D</given-names></name><name><surname>Dang-Lawson</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Priatel</surname><given-names>JJ</given-names></name><name><surname>Coombs</surname><given-names>D</given-names></name><name><surname>Hammer</surname><given-names>JA</given-names></name><name><surname>Gold</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Arp2/3 complex-driven spatial patterning of the BCR enhances immune synapse formation, BCR signaling and B cell activation</article-title><source>eLife</source><volume>8</volume><elocation-id>e44574</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44574</pub-id><pub-id pub-id-type="pmid">31157616</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>NL</given-names></name><name><surname>Pimentel</surname><given-names>H</given-names></name><name><surname>Melsted</surname><given-names>P</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Near-optimal probabilistic RNA-seq quantification</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>525</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nbt.3519</pub-id><pub-id pub-id-type="pmid">27043002</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>VL</given-names></name><name><surname>Ma</surname><given-names>CS</given-names></name><name><surname>Avery</surname><given-names>DT</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Good</surname><given-names>KL</given-names></name><name><surname>Corcoran</surname><given-names>LM</given-names></name><name><surname>de Waal Malefyt</surname><given-names>R</given-names></name><name><surname>Tangye</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cytokine-mediated regulation of human B cell differentiation into ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells</article-title><source>Journal of Immunology</source><volume>179</volume><fpage>8180</fpage><lpage>8190</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.12.8180</pub-id><pub-id pub-id-type="pmid">18056361</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calado</surname><given-names>DP</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Godinho</surname><given-names>SA</given-names></name><name><surname>Pellerin</surname><given-names>A</given-names></name><name><surname>Köchert</surname><given-names>K</given-names></name><name><surname>Sleckman</surname><given-names>BP</given-names></name><name><surname>de Alborán</surname><given-names>IM</given-names></name><name><surname>Janz</surname><given-names>M</given-names></name><name><surname>Rodig</surname><given-names>S</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The cell-cycle regulator c-myc is essential for the formation and maintenance of germinal centers</article-title><source>Nature Immunology</source><volume>13</volume><fpage>1092</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1038/ni.2418</pub-id><pub-id pub-id-type="pmid">23001146</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canzar</surname><given-names>S</given-names></name><name><surname>Neu</surname><given-names>KE</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Wilson</surname><given-names>PC</given-names></name><name><surname>Khan</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Basic: BCR assembly from single cells</article-title><source>Bioinformatics</source><volume>33</volume><fpage>425</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw631</pub-id><pub-id pub-id-type="pmid">28172415</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassese</surname><given-names>G</given-names></name><name><surname>Arce</surname><given-names>S</given-names></name><name><surname>Hauser</surname><given-names>AE</given-names></name><name><surname>Lehnert</surname><given-names>K</given-names></name><name><surname>Moewes</surname><given-names>B</given-names></name><name><surname>Mostarac</surname><given-names>M</given-names></name><name><surname>Muehlinghaus</surname><given-names>G</given-names></name><name><surname>Szyska</surname><given-names>M</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Manz</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals</article-title><source>Journal of Immunology</source><volume>171</volume><fpage>1684</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.4.1684</pub-id><pub-id pub-id-type="pmid">12902466</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>W</given-names></name><name><surname>Eum</surname><given-names>HH</given-names></name><name><surname>Lee</surname><given-names>HO</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Lee</surname><given-names>HB</given-names></name><name><surname>Kim</surname><given-names>KT</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Park</surname><given-names>YH</given-names></name><name><surname>Kan</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Park</surname><given-names>WY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15081</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15081</pub-id><pub-id pub-id-type="pmid">28474673</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Sola</surname><given-names>D</given-names></name><name><surname>Victora</surname><given-names>GD</given-names></name><name><surname>Ying</surname><given-names>CY</given-names></name><name><surname>Phan</surname><given-names>RT</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Nussenzweig</surname><given-names>MC</given-names></name><name><surname>Dalla-Favera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>C-MYC is required for germinal center selection and cyclic re-entry HHS public access</article-title><source>Nature Immunology</source><volume>13</volume><fpage>1083</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1038/ni.2428</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Sola</surname><given-names>D</given-names></name><name><surname>Kung</surname><given-names>J</given-names></name><name><surname>Holmes</surname><given-names>AB</given-names></name><name><surname>Wells</surname><given-names>VA</given-names></name><name><surname>Mo</surname><given-names>T</given-names></name><name><surname>Basso</surname><given-names>K</given-names></name><name><surname>Dalla-Favera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The FoxO1 transcription factor instructs the germinal center dark zone program</article-title><source>Immunity</source><volume>43</volume><fpage>1064</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.10.015</pub-id><pub-id pub-id-type="pmid">26620759</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Mintz</surname><given-names>MA</given-names></name><name><surname>Chou</surname><given-names>MY</given-names></name><name><surname>Kotov</surname><given-names>DI</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Laidlaw</surname><given-names>BJ</given-names></name><name><surname>Cyster</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation</article-title><source>Immunity</source><volume>54</volume><fpage>2256</fpage><lpage>2272</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.08.028</pub-id><pub-id pub-id-type="pmid">34555336</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufort</surname><given-names>FJ</given-names></name><name><surname>Gumina</surname><given-names>MR</given-names></name><name><surname>Ta</surname><given-names>NL</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Heyse</surname><given-names>SA</given-names></name><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Richardson</surname><given-names>AD</given-names></name><name><surname>Seyfried</surname><given-names>TN</given-names></name><name><surname>Chiles</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Glucose-Dependent de novo lipogenesis in B lymphocytes: a requirement for ATP-citrate lyase in lipopolysaccharide-induced differentiation</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>7011</fpage><lpage>7024</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.551051</pub-id><pub-id pub-id-type="pmid">24469453</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagone</surname><given-names>P</given-names></name><name><surname>Sriburi</surname><given-names>R</given-names></name><name><surname>Ward-Chapman</surname><given-names>C</given-names></name><name><surname>Frank</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Gunter</surname><given-names>C</given-names></name><name><surname>Brewer</surname><given-names>JW</given-names></name><name><surname>Jackowski</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Phospholipid biosynthesis program underlying membrane expansion during B-lymphocyte differentiation</article-title><source>The Journal of Biological Chemistry</source><volume>282</volume><fpage>7591</fpage><lpage>7605</lpage><pub-id pub-id-type="doi">10.1074/jbc.M608175200</pub-id><pub-id pub-id-type="pmid">17213195</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glaros</surname><given-names>V</given-names></name><name><surname>Rauschmeier</surname><given-names>R</given-names></name><name><surname>Artemov</surname><given-names>AV</given-names></name><name><surname>Reinhardt</surname><given-names>A</given-names></name><name><surname>Ols</surname><given-names>S</given-names></name><name><surname>Emmanouilidi</surname><given-names>A</given-names></name><name><surname>Gustafsson</surname><given-names>C</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Mirabello</surname><given-names>C</given-names></name><name><surname>Björklund</surname><given-names>ÅK</given-names></name><name><surname>Perez</surname><given-names>L</given-names></name><name><surname>King</surname><given-names>NP</given-names></name><name><surname>Månsson</surname><given-names>R</given-names></name><name><surname>Angeletti</surname><given-names>D</given-names></name><name><surname>Loré</surname><given-names>K</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name><name><surname>Busslinger</surname><given-names>M</given-names></name><name><surname>Kreslavsky</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response</article-title><source>Immunity</source><volume>54</volume><fpage>2005</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.08.017</pub-id><pub-id pub-id-type="pmid">34525339</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatman Zaretsky</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>JJ</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Marshall</surname><given-names>FA</given-names></name><name><surname>Mohrs</surname><given-names>M</given-names></name><name><surname>Pearce</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>T follicular helper cells differentiate from Th2 cells in response to helminth antigens</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>991</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1084/jem.20090303</pub-id><pub-id pub-id-type="pmid">19380637</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldfinger</surname><given-names>M</given-names></name><name><surname>Shmuel</surname><given-names>M</given-names></name><name><surname>Benhamron</surname><given-names>S</given-names></name><name><surname>Tirosh</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protein synthesis in plasma cells is regulated by crosstalk between endoplasmic reticulum stress and mTOR signaling</article-title><source>European Journal of Immunology</source><volume>41</volume><fpage>491</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1002/eji.201040677</pub-id><pub-id pub-id-type="pmid">21268018</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>DG</given-names></name><name><surname>Cote</surname><given-names>CM</given-names></name><name><surname>Patel</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>CB</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Nickerson</surname><given-names>KM</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Kerfoot</surname><given-names>SM</given-names></name><name><surname>Haberman</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nonredundant roles of IL-21 and IL-4 in the phased initiation of germinal center B cells and subsequent self-renewal transitions</article-title><source>Journal of Immunology</source><volume>201</volume><fpage>3569</fpage><lpage>3579</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500497</pub-id><pub-id pub-id-type="pmid">30446568</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliley</surname><given-names>JL</given-names></name><name><surname>Tipton</surname><given-names>CM</given-names></name><name><surname>Liesveld</surname><given-names>J</given-names></name><name><surname>Rosenberg</surname><given-names>AF</given-names></name><name><surname>Darce</surname><given-names>J</given-names></name><name><surname>Gregoretti</surname><given-names>IV</given-names></name><name><surname>Popova</surname><given-names>L</given-names></name><name><surname>Kaminiski</surname><given-names>D</given-names></name><name><surname>Fucile</surname><given-names>CF</given-names></name><name><surname>Albizua</surname><given-names>I</given-names></name><name><surname>Kyu</surname><given-names>S</given-names></name><name><surname>Chiang</surname><given-names>K-Y</given-names></name><name><surname>Bradley</surname><given-names>KT</given-names></name><name><surname>Burack</surname><given-names>R</given-names></name><name><surname>Slifka</surname><given-names>M</given-names></name><name><surname>Hammarlund</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Walsh</surname><given-names>EE</given-names></name><name><surname>Falsey</surname><given-names>AR</given-names></name><name><surname>Randall</surname><given-names>TD</given-names></name><name><surname>Cheung</surname><given-names>WC</given-names></name><name><surname>Sanz</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>FE-H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-lived plasma cells are contained within the CD19(-)CD38(hi)CD138(+) subset in human bone marrow</article-title><source>Immunity</source><volume>43</volume><fpage>132</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.016</pub-id><pub-id pub-id-type="pmid">26187412</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>AB</given-names></name><name><surname>Corinaldesi</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Compagno</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Nitzan</surname><given-names>M</given-names></name><name><surname>Grunstein</surname><given-names>E</given-names></name><name><surname>Pasqualucci</surname><given-names>L</given-names></name><name><surname>Dalla-Favera</surname><given-names>R</given-names></name><name><surname>Basso</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome</article-title><source>The Journal of Experimental Medicine</source><volume>217</volume><elocation-id>e20200483</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20200483</pub-id><pub-id pub-id-type="pmid">32603407</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Goh</surname><given-names>I</given-names></name><name><surname>Quiroga Londoño</surname><given-names>M</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Mather</surname><given-names>M</given-names></name><name><surname>Olabi</surname><given-names>B</given-names></name><name><surname>Stephenson</surname><given-names>E</given-names></name><name><surname>Botting</surname><given-names>RA</given-names></name><name><surname>Horsfall</surname><given-names>D</given-names></name><name><surname>Engelbert</surname><given-names>J</given-names></name><name><surname>Maunder</surname><given-names>D</given-names></name><name><surname>Mende</surname><given-names>N</given-names></name><name><surname>Murnane</surname><given-names>C</given-names></name><name><surname>Dann</surname><given-names>E</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>H</given-names></name><name><surname>Kucinski</surname><given-names>I</given-names></name><name><surname>Queen</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>CD</given-names></name><name><surname>Shrubsole</surname><given-names>C</given-names></name><name><surname>Poyner</surname><given-names>E</given-names></name><name><surname>Acres</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Ness</surname><given-names>T</given-names></name><name><surname>Coulthard</surname><given-names>R</given-names></name><name><surname>Elliott</surname><given-names>N</given-names></name><name><surname>O’Byrne</surname><given-names>S</given-names></name><name><surname>Haltalli</surname><given-names>MLR</given-names></name><name><surname>Lawrence</surname><given-names>JE</given-names></name><name><surname>Lisgo</surname><given-names>S</given-names></name><name><surname>Balogh</surname><given-names>P</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>Prigmore</surname><given-names>E</given-names></name><name><surname>Ambridge</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>MS</given-names></name><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Pickard</surname><given-names>K</given-names></name><name><surname>Creasey</surname><given-names>T</given-names></name><name><surname>Bacardit</surname><given-names>J</given-names></name><name><surname>Henderson</surname><given-names>D</given-names></name><name><surname>Coxhead</surname><given-names>J</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Hussain</surname><given-names>R</given-names></name><name><surname>Dixon</surname><given-names>D</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Popescu</surname><given-names>D-M</given-names></name><name><surname>Kowalczyk</surname><given-names>MS</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Ashenberg</surname><given-names>O</given-names></name><name><surname>Tabaka</surname><given-names>M</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Tickle</surname><given-names>TL</given-names></name><name><surname>Slyper</surname><given-names>M</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>NK</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Roberts</surname><given-names>I</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Blood and immune development in human fetal bone marrow and down syndrome</article-title><source>Nature</source><volume>598</volume><fpage>327</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03929-x</pub-id><pub-id pub-id-type="pmid">34588693</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>C</given-names></name><name><surname>Tangye</surname><given-names>SG</given-names></name><name><surname>Mackay</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>T follicular helper (tfh) cells in normal and dysregulated immune responses</article-title><source>Annual Review of Immunology</source><volume>26</volume><fpage>741</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090344</pub-id><pub-id pub-id-type="pmid">18173374</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Mohrs</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>1001</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1084/jem.20090313</pub-id><pub-id pub-id-type="pmid">19380638</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Nathan</surname><given-names>A</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Presto Scales Wilcoxon and AuROC Analyses to Millions of Observations</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/653253</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laidlaw</surname><given-names>BJ</given-names></name><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Vazquez</surname><given-names>SE</given-names></name><name><surname>Cyster</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The transcription factor hhex cooperates with the corepressor tle3 to promote memory B cell development</article-title><source>Nature Immunology</source><volume>21</volume><fpage>1082</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0713-6</pub-id><pub-id pub-id-type="pmid">32601467</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Ruotti</surname><given-names>V</given-names></name><name><surname>Stewart</surname><given-names>RM</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Dewey</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>RNA-seq gene expression estimation with read mapping uncertainty</article-title><source>Bioinformatics</source><volume>26</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp692</pub-id><pub-id pub-id-type="pmid">20022975</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberzon</surname><given-names>A</given-names></name><name><surname>Birger</surname><given-names>C</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Ghandi</surname><given-names>M</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The molecular signatures database (msigdb) hallmark gene set collection</article-title><source>Cell Systems</source><volume>1</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2015.12.004</pub-id><pub-id pub-id-type="pmid">26771021</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindeman</surname><given-names>I</given-names></name><name><surname>Emerton</surname><given-names>G</given-names></name><name><surname>Mamanova</surname><given-names>L</given-names></name><name><surname>Snir</surname><given-names>O</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Qiao</surname><given-names>SW</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Stubbington</surname><given-names>MJT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BraCeR: B-cell-receptor reconstruction and clonality inference from single-cell RNA-seq</article-title><source>Nature Methods</source><volume>15</volume><fpage>563</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1038/s41592-018-0082-3</pub-id><pub-id pub-id-type="pmid">30065371</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loken</surname><given-names>MR</given-names></name><name><surname>Shah</surname><given-names>VO</given-names></name><name><surname>Dattilio</surname><given-names>KL</given-names></name><name><surname>Civin</surname><given-names>CI</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Flow cytometric analysis of human bone marrow. II. normal B lymphocyte development</article-title><source>Blood</source><volume>70</volume><fpage>1316</fpage><lpage>1324</lpage><pub-id pub-id-type="pmid">3117132</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>NS</given-names></name><name><surname>Lugar</surname><given-names>PL</given-names></name><name><surname>Yavuz</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Krijger</surname><given-names>PHL</given-names></name><name><surname>Russ</surname><given-names>DE</given-names></name><name><surname>Jima</surname><given-names>DD</given-names></name><name><surname>Dave</surname><given-names>SS</given-names></name><name><surname>Grammer</surname><given-names>AC</given-names></name><name><surname>Lipsky</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting</article-title><source>Blood</source><volume>113</volume><fpage>3706</fpage><lpage>3715</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-10-183632</pub-id><pub-id pub-id-type="pmid">19023113</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>SJ</given-names></name><name><surname>Steffensen</surname><given-names>M</given-names></name><name><surname>Acs</surname><given-names>A</given-names></name><name><surname>Weisenburger</surname><given-names>T</given-names></name><name><surname>Wadewitz</surname><given-names>C</given-names></name><name><surname>Winkler</surname><given-names>TH</given-names></name><name><surname>Nitschke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>CD22 controls germinal center B cell receptor signaling, which influences plasma cell and memory B cell output</article-title><source>Journal of Immunology</source><volume>207</volume><fpage>1018</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2100132</pub-id><pub-id pub-id-type="pmid">34330755</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milpied</surname><given-names>P</given-names></name><name><surname>Cervera-Marzal</surname><given-names>I</given-names></name><name><surname>Mollichella</surname><given-names>ML</given-names></name><name><surname>Tesson</surname><given-names>B</given-names></name><name><surname>Brisou</surname><given-names>G</given-names></name><name><surname>Traverse-Glehen</surname><given-names>A</given-names></name><name><surname>Salles</surname><given-names>G</given-names></name><name><surname>Spinelli</surname><given-names>L</given-names></name><name><surname>Nadel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human germinal center transcriptional programs are de-synchronized in B cell lymphoma</article-title><source>Nature Immunology</source><volume>19</volume><fpage>1013</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0181-4</pub-id><pub-id pub-id-type="pmid">30104629</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minnich</surname><given-names>M</given-names></name><name><surname>Tagoh</surname><given-names>H</given-names></name><name><surname>Bönelt</surname><given-names>P</given-names></name><name><surname>Axelsson</surname><given-names>E</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Cebolla</surname><given-names>B</given-names></name><name><surname>Tarakhovsky</surname><given-names>A</given-names></name><name><surname>Nutt</surname><given-names>SL</given-names></name><name><surname>Jaritz</surname><given-names>M</given-names></name><name><surname>Busslinger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation</article-title><source>Nature Immunology</source><volume>17</volume><fpage>331</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1038/ni.3349</pub-id><pub-id pub-id-type="pmid">26779602</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyai</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>J</given-names></name><name><surname>Endo</surname><given-names>TA</given-names></name><name><surname>Kawakami</surname><given-names>E</given-names></name><name><surname>Agata</surname><given-names>Y</given-names></name><name><surname>Motomura</surname><given-names>Y</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Kashima</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Ikawa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Three-Step transcriptional priming that drives the commitment of multipotent progenitors toward B cells</article-title><source>Genes &amp; Development</source><volume>32</volume><fpage>112</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1101/gad.309575.117</pub-id><pub-id pub-id-type="pmid">29440259</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojima</surname><given-names>T</given-names></name><name><surname>Haniuda</surname><given-names>K</given-names></name><name><surname>Moutai</surname><given-names>T</given-names></name><name><surname>Matsudaira</surname><given-names>M</given-names></name><name><surname>Mizokawa</surname><given-names>S</given-names></name><name><surname>Shiratori</surname><given-names>I</given-names></name><name><surname>Azuma</surname><given-names>T</given-names></name><name><surname>Kitamura</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>In-Vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo</article-title><source>Nature Communications</source><volume>2</volume><elocation-id>465</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms1475</pub-id><pub-id pub-id-type="pmid">21897376</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pengo</surname><given-names>N</given-names></name><name><surname>Scolari</surname><given-names>M</given-names></name><name><surname>Oliva</surname><given-names>L</given-names></name><name><surname>Milan</surname><given-names>E</given-names></name><name><surname>Mainoldi</surname><given-names>F</given-names></name><name><surname>Raimondi</surname><given-names>A</given-names></name><name><surname>Fagioli</surname><given-names>C</given-names></name><name><surname>Merlini</surname><given-names>A</given-names></name><name><surname>Mariani</surname><given-names>E</given-names></name><name><surname>Pasqualetto</surname><given-names>E</given-names></name><name><surname>Orfanelli</surname><given-names>U</given-names></name><name><surname>Ponzoni</surname><given-names>M</given-names></name><name><surname>Sitia</surname><given-names>R</given-names></name><name><surname>Casola</surname><given-names>S</given-names></name><name><surname>Cenci</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Plasma cells require autophagy for sustainable immunoglobulin production</article-title><source>Nature Immunology</source><volume>14</volume><fpage>298</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/ni.2524</pub-id><pub-id pub-id-type="pmid">23354484</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picelli</surname><given-names>S</given-names></name><name><surname>Faridani</surname><given-names>OR</given-names></name><name><surname>Björklund</surname><given-names>AK</given-names></name><name><surname>Winberg</surname><given-names>G</given-names></name><name><surname>Sagasser</surname><given-names>S</given-names></name><name><surname>Sandberg</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Full-Length RNA-seq from single cells using smart-seq2</article-title><source>Nature Protocols</source><volume>9</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.006</pub-id><pub-id pub-id-type="pmid">24385147</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Muehlinghaus</surname><given-names>G</given-names></name><name><surname>Luger</surname><given-names>EO</given-names></name><name><surname>Inamine</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>KGC</given-names></name><name><surname>Dörner</surname><given-names>T</given-names></name><name><surname>Hiepe</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Competence and competition: the challenge of becoming a long-lived plasma cell</article-title><source>Nature Reviews. Immunology</source><volume>6</volume><fpage>741</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1038/nri1886</pub-id><pub-id pub-id-type="pmid">16977339</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhardt</surname><given-names>RL</given-names></name><name><surname>Liang</surname><given-names>HE</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cytokine-Secreting follicular T cells shape the antibody repertoire</article-title><source>Nature Immunology</source><volume>10</volume><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/ni.1715</pub-id><pub-id pub-id-type="pmid">19252490</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzetto</surname><given-names>S</given-names></name><name><surname>Koppstein</surname><given-names>DNP</given-names></name><name><surname>Samir</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Reed</surname><given-names>JH</given-names></name><name><surname>Cai</surname><given-names>CH</given-names></name><name><surname>Lloyd</surname><given-names>AR</given-names></name><name><surname>Eltahla</surname><given-names>AA</given-names></name><name><surname>Goodnow</surname><given-names>CC</given-names></name><name><surname>Luciani</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>B-cell receptor reconstruction from single-cell RNA-seq with vdjpuzzle</article-title><source>Bioinformatics</source><volume>34</volume><fpage>2846</fpage><lpage>2847</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty203</pub-id><pub-id pub-id-type="pmid">29659703</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roper</surname><given-names>SI</given-names></name><name><surname>Wasim</surname><given-names>L</given-names></name><name><surname>Malinova</surname><given-names>D</given-names></name><name><surname>Way</surname><given-names>M</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name><name><surname>Tolar</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>B cells extract antigens at arp2/3-generated actin foci interspersed with linear filaments</article-title><source>eLife</source><volume>8</volume><elocation-id>e48093</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.48093</pub-id><pub-id pub-id-type="pmid">31815664</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Todorov</surname><given-names>H</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A comparison of single-cell trajectory inference methods</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0071-9</pub-id><pub-id pub-id-type="pmid">30936559</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>S</given-names></name><name><surname>Chu</surname><given-names>VT</given-names></name><name><surname>Yasuda</surname><given-names>T</given-names></name><name><surname>Franklin</surname><given-names>A</given-names></name><name><surname>Graf</surname><given-names>R</given-names></name><name><surname>Calado</surname><given-names>DP</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Imami</surname><given-names>K</given-names></name><name><surname>Selbach</surname><given-names>M</given-names></name><name><surname>Di Virgilio</surname><given-names>M</given-names></name><name><surname>Bullinger</surname><given-names>L</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pi3 kinase and FoxO1 transcription factor activity differentially control B cells in the germinal center light and dark zones</article-title><source>Immunity</source><volume>43</volume><fpage>1075</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.10.021</pub-id><pub-id pub-id-type="pmid">26620760</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>RD</given-names></name><name><surname>Lalor</surname><given-names>P</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>B lymphocytes express and lose syndecan at specific stages of differentiation</article-title><source>Cell Regulation</source><volume>1</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1091/mbc.1.1.27</pub-id><pub-id pub-id-type="pmid">2519615</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>I</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><name><surname>Jenks</surname><given-names>SA</given-names></name><name><surname>Cashman</surname><given-names>KS</given-names></name><name><surname>Tipton</surname><given-names>C</given-names></name><name><surname>Woodruff</surname><given-names>MC</given-names></name><name><surname>Hom</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>FEH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Challenges and opportunities for consistent classification of human B cell and plasma cell populations</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>2458</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02458</pub-id><pub-id pub-id-type="pmid">31681331</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KGC</given-names></name><name><surname>Light</surname><given-names>A</given-names></name><name><surname>Nossal</surname><given-names>GJ</given-names></name><name><surname>Tarlinton</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response</article-title><source>The EMBO Journal</source><volume>16</volume><fpage>2996</fpage><lpage>3006</lpage><pub-id pub-id-type="doi">10.1093/emboj/16.11.2996</pub-id><pub-id pub-id-type="pmid">9214617</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title><source>F1000Research</source><volume>4</volume><elocation-id>1521</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.7563.2</pub-id><pub-id pub-id-type="pmid">26925227</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souwer</surname><given-names>Y</given-names></name><name><surname>Griekspoor</surname><given-names>A</given-names></name><name><surname>Jorritsma</surname><given-names>T</given-names></name><name><surname>de Wit</surname><given-names>J</given-names></name><name><surname>Janssen</surname><given-names>H</given-names></name><name><surname>Neefjes</surname><given-names>J</given-names></name><name><surname>van Ham</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production</article-title><source>Journal of Immunology</source><volume>182</volume><fpage>7473</fpage><lpage>7481</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0802831</pub-id><pub-id pub-id-type="pmid">19494270</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>HJ</given-names></name><name><surname>Aye</surname><given-names>R</given-names></name><name><surname>Idris</surname><given-names>AH</given-names></name><name><surname>Vistein</surname><given-names>R</given-names></name><name><surname>Nduati</surname><given-names>E</given-names></name><name><surname>Kai</surname><given-names>O</given-names></name><name><surname>Mwacharo</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Andrews</surname><given-names>TD</given-names></name><name><surname>Koutsakos</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>THO</given-names></name><name><surname>Nekrasov</surname><given-names>M</given-names></name><name><surname>Milburn</surname><given-names>P</given-names></name><name><surname>Eltahla</surname><given-names>A</given-names></name><name><surname>Berry</surname><given-names>AA</given-names></name><name><surname>Kc</surname><given-names>N</given-names></name><name><surname>Chakravarty</surname><given-names>S</given-names></name><name><surname>Sim</surname><given-names>BKL</given-names></name><name><surname>Wheatley</surname><given-names>AK</given-names></name><name><surname>Kent</surname><given-names>SJ</given-names></name><name><surname>Hoffman</surname><given-names>SL</given-names></name><name><surname>Lyke</surname><given-names>KE</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Luciani</surname><given-names>F</given-names></name><name><surname>Kedzierska</surname><given-names>K</given-names></name><name><surname>Seder</surname><given-names>RA</given-names></name><name><surname>Ndungu</surname><given-names>FM</given-names></name><name><surname>Cockburn</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans</article-title><source>Cell Reports</source><volume>34</volume><elocation-id>108684</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108684</pub-id><pub-id pub-id-type="pmid">33567273</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangye</surname><given-names>SG</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Aversa</surname><given-names>G</given-names></name><name><surname>Phillips</surname><given-names>JH</given-names></name><name><surname>de Vries</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Identification of functional human splenic memory B cells by expression of CD148 and CD27</article-title><source>The Journal of Experimental Medicine</source><volume>188</volume><fpage>1691</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1084/jem.188.9.1691</pub-id><pub-id pub-id-type="pmid">9802981</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarte</surname><given-names>K</given-names></name><name><surname>Zhan</surname><given-names>F</given-names></name><name><surname>De Vos</surname><given-names>J</given-names></name><name><surname>Klein</surname><given-names>B</given-names></name><name><surname>Shaughnessy</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation</article-title><source>Blood</source><volume>102</volume><fpage>592</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-10-3161</pub-id><pub-id pub-id-type="pmid">12663452</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terstappen</surname><given-names>LW</given-names></name><name><surname>Johnsen</surname><given-names>S</given-names></name><name><surname>Segers-Nolten</surname><given-names>IM</given-names></name><name><surname>Loken</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry</article-title><source>Blood</source><volume>76</volume><fpage>1739</fpage><lpage>1747</lpage><pub-id pub-id-type="doi">10.1182/blood.V76.9.1739.1739</pub-id><pub-id pub-id-type="pmid">2224123</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname><given-names>P-PA</given-names></name><name><surname>Verstegen</surname><given-names>NJM</given-names></name><name><surname>Marsman</surname><given-names>C</given-names></name><name><surname>Jorritsma</surname><given-names>T</given-names></name><name><surname>Rispens</surname><given-names>T</given-names></name><name><surname>Ten Brinke</surname><given-names>A</given-names></name><name><surname>van Ham</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Minimalistic in vitro culture to drive human naive B cell differentiation into antibody-secreting cells</article-title><source>Cells</source><volume>10</volume><elocation-id>1183</elocation-id><pub-id pub-id-type="doi">10.3390/cells10051183</pub-id><pub-id pub-id-type="pmid">34066151</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>AA</given-names></name><name><surname>Kauffman</surname><given-names>RC</given-names></name><name><surname>Wolabaugh</surname><given-names>AN</given-names></name><name><surname>Cho</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>NB</given-names></name><name><surname>Reiss</surname><given-names>SM</given-names></name><name><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name><surname>Dawoud</surname><given-names>RA</given-names></name><name><surname>Tharp</surname><given-names>GK</given-names></name><name><surname>Sanz</surname><given-names>I</given-names></name><name><surname>Pulendran</surname><given-names>B</given-names></name><name><surname>Crotty</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>FEH</given-names></name><name><surname>Wrammert</surname><given-names>J</given-names></name><name><surname>Bosinger</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data</article-title><source>Genome Medicine</source><volume>10</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-018-0528-3</pub-id><pub-id pub-id-type="pmid">29558968</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urashima</surname><given-names>M</given-names></name><name><surname>Chauhan</surname><given-names>D</given-names></name><name><surname>Hatziyanni</surname><given-names>M</given-names></name><name><surname>Ogata</surname><given-names>A</given-names></name><name><surname>Hollenbaugh</surname><given-names>D</given-names></name><name><surname>Aruffo</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cd40 ligand triggers interleukin-6 mediated B cell differentiation</article-title><source>Leukemia Research</source><volume>20</volume><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/0145-2126(95)00098-4</pub-id><pub-id pub-id-type="pmid">8709623</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verstegen</surname><given-names>NJM</given-names></name><name><surname>Ubels</surname><given-names>V</given-names></name><name><surname>Westerhoff</surname><given-names>HV</given-names></name><name><surname>van Ham</surname><given-names>SM</given-names></name><name><surname>Barberis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>System-level scenarios for the elucidation of T cell-mediated germinal center B cell differentiation</article-title><source>Frontiers in Immunology</source><volume>12</volume><elocation-id>734282</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.734282</pub-id><pub-id pub-id-type="pmid">34616402</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Victora</surname><given-names>GD</given-names></name><name><surname>Dominguez-Sola</surname><given-names>D</given-names></name><name><surname>Holmes</surname><given-names>AB</given-names></name><name><surname>Deroubaix</surname><given-names>S</given-names></name><name><surname>Dalla-Favera</surname><given-names>R</given-names></name><name><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas</article-title><source>Blood</source><volume>120</volume><fpage>2240</fpage><lpage>2248</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-03-415380</pub-id><pub-id pub-id-type="pmid">22740445</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Victora</surname><given-names>G.D</given-names></name><name><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Germinal centers</article-title><source>Annual Review of Immunology</source><volume>40</volume><fpage>413</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-120419-022408</pub-id><pub-id pub-id-type="pmid">35113731</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Karnell</surname><given-names>JL</given-names></name><name><surname>Naiman</surname><given-names>B</given-names></name><name><surname>Gross</surname><given-names>PS</given-names></name><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Zerrouki</surname><given-names>K</given-names></name><name><surname>Hanna</surname><given-names>R</given-names></name><name><surname>Morehouse</surname><given-names>C</given-names></name><name><surname>Holoweckyj</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><collab>Autoimmunity Molecular Medicine Team</collab><name><surname>Casey</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>N</given-names></name><name><surname>Riggs</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>B</given-names></name><name><surname>Bhat</surname><given-names>G</given-names></name><name><surname>Rajan</surname><given-names>B</given-names></name><name><surname>Grady</surname><given-names>R</given-names></name><name><surname>Groves</surname><given-names>C</given-names></name><name><surname>Manna</surname><given-names>Z</given-names></name><name><surname>Goldbach-Mansky</surname><given-names>R</given-names></name><name><surname>Hasni</surname><given-names>S</given-names></name><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Sanjuan</surname><given-names>M</given-names></name><name><surname>Streicher</surname><given-names>K</given-names></name><name><surname>Cancro</surname><given-names>MP</given-names></name><name><surname>Kolbeck</surname><given-names>R</given-names></name><name><surname>Ettinger</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Il-21 drives expansion and plasma cell differentiation of autoreactive cd11chit-bet+ B cells in SLE</article-title><source>Nature Communications</source><volume>9</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/s41467-018-03750-7</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>JX</given-names></name><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Naghashfar</surname><given-names>Z</given-names></name><name><surname>Abbasi</surname><given-names>S</given-names></name><name><surname>Kovalchuk</surname><given-names>AL</given-names></name><name><surname>Bolland</surname><given-names>S</given-names></name><name><surname>Nutt</surname><given-names>SL</given-names></name><name><surname>Leonard</surname><given-names>WJ</given-names></name><name><surname>Morse</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses</article-title><source>PNAS</source><volume>116</volume><fpage>9511</fpage><lpage>9520</lpage><pub-id pub-id-type="doi">10.1073/pnas.1901258116</pub-id><pub-id pub-id-type="pmid">31000603</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisel</surname><given-names>FJ</given-names></name><name><surname>Zuccarino-Catania</surname><given-names>GV</given-names></name><name><surname>Chikina</surname><given-names>M</given-names></name><name><surname>Shlomchik</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A temporal switch in the germinal center determines differential output of memory B and plasma cells</article-title><source>Immunity</source><volume>44</volume><fpage>116</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.12.004</pub-id><pub-id pub-id-type="pmid">26795247</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Hamey</surname><given-names>FK</given-names></name><name><surname>Plass</surname><given-names>M</given-names></name><name><surname>Solana</surname><given-names>J</given-names></name><name><surname>Dahlin</surname><given-names>JS</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Rajewsky</surname><given-names>N</given-names></name><name><surname>Simon</surname><given-names>L</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1663-x</pub-id><pub-id pub-id-type="pmid">30890159</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusuf</surname><given-names>I</given-names></name><name><surname>Kageyama</surname><given-names>R</given-names></name><name><surname>Monticelli</surname><given-names>L</given-names></name><name><surname>Johnston</surname><given-names>RJ</given-names></name><name><surname>Ditoro</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Barnett</surname><given-names>B</given-names></name><name><surname>Crotty</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150)</article-title><source>Journal of Immunology</source><volume>185</volume><fpage>190</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903505</pub-id><pub-id pub-id-type="pmid">20525889</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83578.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Murim</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.10.03.510595" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.03.510595"/></front-stub><body><p>To recapitulate B cell differentiation process in vitro, the authors established an in vitro system to identify a cluster and performed extensive analyses to demonstrate that the cluster mimics human germinal center antibody-secreting cells (ASCs). They provide stepwise trajectories of plasma cell differentiation from human naive B cells upon stimulation with CD40 ligands, IL-4, and IL-21. Since intermediate clusters of cells show features of germinal center B cells, the authors propose novel intermediate stages of B cells before a complete differentiation into plasma cells. This study is valuable in the differentiation of primary naive B cells into ASC ex vivo and may interest immunologists with an emphasis in B cell biology as it provides an in-depth description of the B cell differentiation pathways.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83578.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Choi</surname><given-names>Murim</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Choi</surname><given-names>Murim</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.03.510595">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.10.03.510595v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, including Murim Choi as the Senior Editor, Reviewing Editor and Reviewer #1.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The reviewers agreed with the value and novelty of the study, especially on not much studied B cell differentiation. But they also thought that substantial revisions are needed to guarantee publication in <italic>eLife</italic>. For example, the major concerns were</p><p>(1) Both reviewers showed concern on normalizing cell cycle effect would overfit the data.</p><p>(2) The degree their in vitro model to recapitulate in vivo situation.</p><p>(3) Description on methods for replication in other groups, and difference from the previous paper (Unger 2021).</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This work is interesting and provides an in-depth description of the B cell differentiation pathways. However, this work has several pitfalls, which may decrease the value of this manuscript.</p><p>1. This study uses in vitro system of germinal center B or plasma cell differentiation from human naive B cells. Even though cells of clusters 4 and 5 express the ASC genes also found in vivo, these in vitro generated cells may still be different from in vivo plasma cells in other gene expression profiles determined by in vivo conditions. Therefore, a novel pre-ASC population could be found only in vitro. The in vitro B cell culture system is suitable for the investigation of molecular differentiation mechanism but may be not ideal for the description of differentiation trajectory or pathway.</p><p>2. The authors removed the influence of the cell cycle by performing cell cycle regression, which is good for removing the effects of the genes oscillating with the cell cycle. But, the cell division numbers may affect the choice between memory B cell and plasma cell differentiation [Zhou, Front Immunol, 9:2053; Duffy, Science, 335:338]. More ASCs may appear after multiple rounds of cell division stochastically. Therefore, it would be nice to follow gene expression profiles with cell division numbers or different time points of culture.</p><p>3. IL-21 and IL-4 are principal cytokines for germinal center reaction and CD40/CD40L interaction is essential for GC formation. So the culture condition appears to favor the GC-like cells initially, and ASCs may appear late after multiple rounds of cell division. Therefore, the author's argument of the first identification of GC-like B cells may be regarded as a case of the human counterpart of GC B cell culture of mice [Gonzalez, J Immunol, 201:3569].</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83578.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This work is interesting and provides an in-depth description of the B cell differentiation pathways. However, this work has several pitfalls, which may decrease the value of this manuscript.</p><p>1. This study uses in vitro system of germinal center B or plasma cell differentiation from human naive B cells. Even though cells of clusters 4 and 5 express the ASC genes also found in vivo, these in vitro generated cells may still be different from in vivo plasma cells in other gene expression profiles determined by in vivo conditions. Therefore, a novel pre-ASC population could be found only in vitro. The in vitro B cell culture system is suitable for the investigation of molecular differentiation mechanism but may be not ideal for the description of differentiation trajectory or pathway.</p></disp-quote><p>We appreciate the insight provided by the reviewer regarding the potential differences between in vitro and in vivo generated ASCs and now specifically addressed this point in our manuscript: We observed that a significant portion of the differentially expressed genes in our in vitro ASCs are not shared with ex vivo ASC populations. Specifically, 293 out of 1406 genes (20%) identified in clusters 4 and 5 were unique to our in vitro ASCs (Figure 2h). Additionally, we have conducted additional comparisons and found that ex vivo ASC populations also possess unique differentially expressed genes that are not shared with other ex vivo <italic>or</italic> in vitro<italic>-generated</italic> ASC populations (Figure 2i). These findings indicate that in vivo ASCs carry specific, possibly tissue-related, gene signatures in addition to the &quot;core ASC signature&quot; shared among ASCs. We have added this in the current manuscript (line 360-363).</p><p>In regard to the question of whether the pre-ASC cell population observed in our in vitro system is in fact present in vivo, we agree with the reviewer that we did not prove the presence of the same population in vivo setting. However, we did show transcriptional overlap between cells in cluster 4 and small population of B cell in ex-vivo obtained tissues with active ASC formation (Figure3h). Additionally, in the recently published study by Sanz <italic>et al.,</italic> Front. Immunol. the authors identified a pre-ASC population in the peripheral blood of healthy volunteers six days post-vaccination. These cells displayed intermediate CD27 and CD38 expression, lower expression of PRDM1, and higher expression of PAX5 compared to CD138 plasma blasts, which are consistent with the characteristics observed in cluster 4 of our study (Figure 1—figure supplement 2 and Figure 1l-m). Therefore, we believe that our in vitro pre-ASC population is likely the same as the one found in vivo, however, it may be challenging to identify in normal steady-state conditions as it only appears transiently during ASC formation. We have rephrased our conclusion according and added the aforementioned speculation in the discussion (lines 471-477).</p><disp-quote content-type="editor-comment"><p>2. The authors removed the influence of the cell cycle by performing cell cycle regression, which is good for removing the effects of the genes oscillating with the cell cycle. But, the cell division numbers may affect the choice between memory B cell and plasma cell differentiation [Zhou, Front Immunol, 9:2053; Duffy, Science, 335:338]. More ASCs may appear after multiple rounds of cell division stochastically. Therefore, it would be nice to follow gene expression profiles with cell division numbers or different time points of culture.</p></disp-quote><p>In regards to the concerns about the cell-cycle regression step in our bioinformatic pipeline, we fully agree with the reviewer and know that the cell cycle plays a significant role in B cell differentiation output trajectories. Preparing the manuscript, we have in fact performed a parallel analysis in which we compared both cell cycle regressed- and not cell cycle regressed-based clustering and marker gene selection. Concerning the clustering, other clusters were obtained using the not cell-cycle-regressed dataset compared to the cell-cycle-regressed dataset (figure below). However, when overlaying the clusters obtained with the cell cycle-regressed dataset, the extra clusters were the same cell population but now split based on cycling and not cycling cells: cluster 2 is now divided into the cycling cluster “c”, and the not-cycling cluster “d” while cluster 4 and 5 are now divided into the cycling clusters “e” and the not-cycling cluster “f”. A comprehensive examination of the expression of the top 50 genes associated with antibody-secreting cells in the (non)cycling clusters 4 and 5 reveals that these genes are expressed at a higher level in (non)cycling cluster 5 as compared to cluster 4. This suggests that the cells within cluster 5 are more advanced in their differentiation, regardless of their cell cycle state. This finding has led us to the decision to present the data that has undergone cell cycle regression in the manuscript. Should the reviewer so desire, we are very willing to include additional figures in the manuscript that include the un-regressed representation.</p><p>With regards to the suggestion of further investigating the effect of cell division numbers on differentiation pathway choice, we have already conducted research in this area and have recently published our findings (Marsman <italic>et al.</italic>, Cells 2020). We recognize the value in further exploring this topic by conducting a single-cell analysis of the entire culture system at different time points and incorporating a proliferation dye in the starting cell population. As these conditions were not included in the present study, we are unable to provide further insight at this time. However, we are currently in the process of setting up such experiments and hope to present the results in the near future.</p><disp-quote content-type="editor-comment"><p>3. IL-21 and IL-4 are principal cytokines for germinal center reaction and CD40/CD40L interaction is essential for GC formation. So the culture condition appears to favor the GC-like cells initially, and ASCs may appear late after multiple rounds of cell division. Therefore, the author's argument of the first identification of GC-like B cells may be regarded as a case of the human counterpart of GC B cell culture of mice [Gonzalez, J Immunol, 201:3569].</p></disp-quote><p>We thank the reviewer for the point raised. We are in total agreement, while a similar culture system is well-established and commonly used in mouse B cell biology, studies utilizing human B cells are limited in comparison. To the best of our knowledge, our study represents the first comprehensive analysis of such a system in humans. We have now added another comparative sentence to the mice studies in our manuscript (lines 481-483).</p></body></sub-article></article>